Annotation Detail for PARP1
Basic Information Top
| Gene Symbol: | PARP1 ( ADPRT,ADPRT 1,ADPRT1,PARP,PARP-1,PPOL,pADPRT-1 ) |
|---|---|
| Gene Full Name: | poly (ADP-ribose) polymerase 1 |
| Band: | 1q42.12 |
| Quick Links | Entrez ID:142; OMIM: 173870; Uniprot ID:PARP1_HUMAN; ENSEMBL ID: ENSG00000143799; HGNC ID: 270 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Desease ID | Desease Name |
|---|---|
| 1709 | Parkinson disease |
| 1720 | Fanconi's anemia |
| 1758 | Common cold |
| 1770 | Melanoma |
| 1781 | Rheumatoid arthritis |
| 1804 | Chronic obstructive airway disease |
| 1878 | Ischemia |
| 1904 | Diabetes mellitus |
| 1935 | Ewings sarcoma |
| 1944 | Breast cancer |
| 2202 | Kidney tubular necrosis, acute |
| 2022 | Liver cancer |
| 2051 | Leukemia |
| 2075 | Heart failure |
| 2132 | Kaposi sarcoma |
| 2134 | Amyotrophic lateral sclerosis |
| 2152 | Renal tubular acidosis |
| 2169 | Pituitary tumor |
| 2171 | Celiac disease |
| 2218 | Werner syndrome |
| 2227 | Uterine fibroids |
| Desease Name |
|---|
| rheumatoid arthritis |
| arthritis |
| Parkinson's disease |
| predisposition to cancer |
| Alzheimer's disease |
| CANCER |
| glomerulonephritis |
| Asthma |
| RENAL |
| Neoplasms |
| IMMUNE |
| NEUROLOGICAL |
| METABOLIC |
| lupus erythematosus |
| lung cancer |
| Lupus |
| diabetes, type 2 |
| No data |
| Desease Name |
|---|
| Xeroderma pigmentosum |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C006718 | 1,12-benzoperylene | 1,12-benzoperylene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in increased cleavage of PARP1 protein | increases cleavage | 15498850 |
| C402108 | 1,5-isoquinolinediol | 1,5-isoquinolinediol results in decreased expression of PARP1 protein | decreases expression | 12824290 |
| C402108 | 1,5-isoquinolinediol | 1,5-isoquinolinediol results in decreased activity of PARP1 protein | decreases activity | 12824290 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15905586 |
| C482402 | 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol | 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol results in increased cleavage of PARP1 protein | increases cleavage | 12963989 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of PARP1 protein | increases activity | 16884709 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14640974 |
| C506698 | 2,5-dimethylcelecoxib | 2,5-dimethylcelecoxib results in increased cleavage of PARP1 protein | increases cleavage | 16123214 |
| C484327 | 2'-benzoyloxycinnamaldehyde | 2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein | increases cleavage | 14660655 |
| C484327 | 2'-benzoyloxycinnamaldehyde | Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14660655 |
| C484327 | 2'-benzoyloxycinnamaldehyde | Glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14660655 |
| C031278 | 2-chloroethyl ethyl sulfide | PARP1 protein affects the susceptibility to 2-chloroethyl ethyl sulfide | affects response to substance | 19111594 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased cleavage of PARP1 protein | increases cleavage | 17363558 |
| C436284 | 2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole | 2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole results in decreased cleavage of PARP1 protein | decreases cleavage | 11478917 |
| C500344 | 2-methoxyestradiol-3,17-bis-O,O-sulfamate | 2-methoxyestradiol-3,17-bis-O,O-sulfamate results in increased cleavage of PARP1 protein | increases cleavage | 15258464 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | PARP1 protein affects the reaction [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased activity of ATM protein] | affects reaction|decreases activity | 16556909 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | PARP1 protein affects the susceptibility to 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | affects response to substance | 16556909 |
| C479235 | 2-(morpholin-4-yl)benzo(h)chromen-4-one | PARP1 protein affects the reaction [2-(morpholin-4-yl)benzo(h)chromen-4-one results in decreased activity of PRKDC protein] | affects reaction|decreases activity | 16556909 |
| C479235 | 2-(morpholin-4-yl)benzo(h)chromen-4-one | PARP1 protein affects the susceptibility to 2-(morpholin-4-yl)benzo(h)chromen-4-one | affects response to substance | 16556909 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of PARP1 protein | increases activity | 16884709 |
| C513485 | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester results in increased cleavage of PARP1 protein | increases cleavage | 16039525 |
| C108729 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone results in decreased activity of PARP1 protein | decreases activity | 15486061 |
| C108729 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone results in decreased activity of PARP1 protein | decreases activity | 14769338 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile results in increased cleavage of and results in increased activity of PARP1 protein | increases activity|increases cleavage | 16173963 |
| C025160 | 3-aminobenzamide | 3-aminobenzamide results in decreased activity of PARP1 protein | decreases activity | 15670817 19056730 |
| C025160 | 3-aminobenzamide | 3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to Acetaminophen] | decreases reaction|increases response to substance | 15601672 |
| C025160 | 3-aminobenzamide | 3-aminobenzamide results in decreased activity of PARP1 protein | decreases activity | 17884996 12824290 |
| C002385 | 3-morpholino-sydnonimine | 3-morpholino-sydnonimine results in decreased expression of PARP1 protein | decreases expression | 12880480 |
| C002385 | 3-morpholino-sydnonimine | Selegiline inhibits the reaction [3-morpholino-sydnonimine results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 12880480 |
| C496751 | 4-(1H-imidazol-1-yl)retinoic acid | 4-(1H-imidazol-1-yl)retinoic acid results in increased cleavage of PARP1 protein | increases cleavage | 17387344 |
| C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of PARP1 mRNA | increases expression | 18648102 |
| C086538 | 4-amino-1,8-naphthalimide | 4-amino-1,8-naphthalimide inhibits the reaction [Doxorubicin results in increased activity of PARP1 protein] | decreases reaction|increases activity | 15456408 |
| C086538 | 4-amino-1,8-naphthalimide | 4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein | decreases activity | 16556909 |
| C086538 | 4-amino-1,8-naphthalimide | ATM protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein] | affects reaction|decreases activity | 16556909 |
| C086538 | 4-amino-1,8-naphthalimide | PARP1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of ATM protein] | affects reaction|increases phosphorylation | 16556909 |
| C086538 | 4-amino-1,8-naphthalimide | PARP1 protein affects the reaction [4-amino-1,8-naphthalimide results in increased phosphorylation of CHEK2 protein] | affects reaction|increases phosphorylation | 16556909 |
| C086538 | 4-amino-1,8-naphthalimide | PRKDC protein affects the reaction [4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein] | affects reaction|decreases activity | 16556909 |
| C086538 | 4-amino-1,8-naphthalimide | 4-amino-1,8-naphthalimide results in decreased activity of PARP1 protein | decreases activity | 14769338 |
| C035207 | 4-amino-2,6-dinitrotoluene | 4-amino-2,6-dinitrotoluene affects the expression of PARP1 mRNA | affects expression | 21346803 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased degradation of PARP1 protein | increases degradation | 11488593 |
| C503119 | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased cleavage of PARP1 protein | increases cleavage | 15831436 |
| C110962 | 5,6-dichlorobenzimidazole | 5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15688023 |
| C411425 | 5-aminoisoquinolinone | 5-aminoisoquinolinone inhibits the reaction [PARP1 protein results in increased susceptibility to Acetaminophen] | decreases reaction|increases response to substance | 15601672 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc Sulfate results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| C054852 | 7-hydroxystaurosporine | [flavopiridol co-treated with 7-hydroxystaurosporine] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 16012789 |
| C522803 | 7-monohydroxyethylrutoside | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17285121 |
| C522803 | 7-monohydroxyethylrutoside | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17285121 |
| C037112 | 9-deoxy-delta-9-prostaglandin D2 | 9-deoxy-delta-9-prostaglandin D2 results in increased cleavage of PARP1 protein | increases cleavage | 15843042 |
| C042553 | acenaphthylene | acenaphthylene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| D000082 | Acetaminophen | 3-aminobenzamide inhibits the reaction [PARP1 protein results in increased susceptibility to Acetaminophen] | decreases reaction|increases response to substance | 15601672 |
| D000082 | Acetaminophen | 5-aminoisoquinolinone inhibits the reaction [PARP1 protein results in increased susceptibility to Acetaminophen] | decreases reaction|increases response to substance | 15601672 |
| D000082 | Acetaminophen | Acetaminophen results in increased activity of PARP1 protein | increases activity | 15601672 |
| D000082 | Acetaminophen | PARP1 protein results in increased susceptibility to Acetaminophen | increases response to substance | 15601672 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PARP1 mRNA | increases expression | 16751229 |
| C099158 | acetyl-aspartyl-glutamyl-valyl-aspartal | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Mustard Gas results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 12482751 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14660655 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 18384088 |
| D000171 | Acrolein | Acrolein results in increased cleavage of PARP1 protein | increases cleavage | 17320762 |
| D000171 | Acrolein | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Acrolein results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17320762 |
| D000171 | Acrolein | Acrolein results in increased cleavage of PARP1 protein | increases cleavage | 19596284 |
| C103303 | alitretinoin | alitretinoin results in increased cleavage of PARP1 protein | increases cleavage | 16449964 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14645110 |
| D000584 | Amiloride | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16059913 15607733 |
| D000584 | Amiloride | Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage|increases reaction | 16059913 |
| D019804 | Mesalamine | Mesalamine results in increased cleavage of PARP1 protein | increases cleavage | 12663503 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PARP1 mRNA | affects expression | 16483693 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16328441 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15501958 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17292878 |
| C037554 | antimony trioxide | antimony trioxide results in increased cleavage of PARP1 protein | increases cleavage | 16112521 |
| C037554 | antimony trioxide | Glutathione deficiency promotes the reaction [antimony trioxide results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16112521 |
| D000968 | Antimycin A | [Antimycin A co-treated with Paraquat] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 16237197 |
| D000968 | Antimycin A | Antimycin A results in increased cleavage of PARP1 protein | increases cleavage | 16237197 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C006632 | arsenic trioxide | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16328441 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of PARP1 protein | decreases expression | 19695276 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of and results in increased activity of PARP1 protein | increases activity|increases cleavage | 19408305 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of PARP1 protein | increases cleavage | 16646077 19364129 16328441 20435036 |
| C006632 | arsenic trioxide | PRDX3 protein affects the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of PARP1 protein] | affects reaction|increases activity|increases cleavage | 19408305 |
| C006632 | arsenic trioxide | SB 203580 inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16328441 |
| C015001 | arsenite | arsenite results in decreased activity of PARP1 protein | decreases activity | 17011244 |
| C015001 | arsenite | arsenite results in increased cleavage of PARP1 protein | increases cleavage | 20083129 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| C517975 | AZD 6244 | AZD 6244 results in increased cleavage of PARP1 protein | increases cleavage | 17876044 |
| C517975 | AZD 6244 | Doxorubicin promotes the reaction [AZD 6244 results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17876044 |
| C012765 | bakuchiol | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17292878 |
| C012765 | bakuchiol | bakuchiol results in increased cleavage of PARP1 protein | increases cleavage | 17292878 |
| C012765 | bakuchiol | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17292878 |
| C001758 | bendamustine | bendamustine results in increased cleavage of PARP1 protein | increases cleavage | 12948851 |
| D001542 | Benomyl | Benomyl results in increased cleavage of PARP1 protein | increases cleavage | 16903866 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C037689 | benzamide | benzamide results in decreased activity of PARP1 protein | decreases activity | 14769338 |
| D001554 | Benzene | Benzene analog results in increased cleavage of PARP1 protein | increases cleavage | 15826604 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PARP1 mRNA | decreases expression | 20064835 |
| D001564 | Benzo(a)pyrene | PARP1 protein results in decreased susceptibility to Benzo(a)pyrene | decreases response to substance | 19247804 |
| C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17404069 |
| C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [bakuchiol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17292878 |
| C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Dieldrin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15183012 |
| C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Acrolein results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17320762 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of PARP1 protein | increases cleavage | 16051428 15498850 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [gemcitabine results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17146438 |
| C103712 | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14640974 |
| D001599 | Berberine | Berberine results in increased cleavage of PARP1 protein | increases cleavage | 16505103 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| D001761 | Bleomycin | Bleomycin results in increased cleavage of PARP1 protein | increases cleavage | 15371238 |
| C400082 | bortezomib | [bortezomib co-treated with Butyrates] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 12893773 |
| C400082 | bortezomib | [bortezomib co-treated with vorinostat] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 12893773 |
| C400082 | bortezomib | [Curcumin co-treated with bortezomib] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19372569 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| D020122 | tert-Butylhydroperoxide | Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16753784 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased cleavage of PARP1 protein | increases cleavage | 16753784 |
| D020122 | tert-Butylhydroperoxide | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15569404 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased cleavage of PARP1 protein | increases cleavage | 15569404 |
| D002087 | Butyrates | [bortezomib co-treated with Butyrates] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 12893773 |
| D002087 | Butyrates | Butyrates results in increased cleavage of PARP1 protein | increases cleavage | 17431121 |
| D002087 | Butyrates | Butyrates results in increased degradation of PARP1 protein | increases degradation | 15177505 |
| C488734 | C 1305 | PARP1 gene mutant form results in increased susceptibility to C 1305 | increases response to substance | 15231658 |
| D002104 | Cadmium | Cadmium results in decreased activity of PARP1 protein | decreases activity | 16677676 |
| D002104 | Cadmium | Cadmium results in increased cleavage of PARP1 protein | increases cleavage | 16785314 |
| D002104 | Cadmium | GLRX protein inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16785314 |
| D002104 | Cadmium | oxalomalic acid promotes the reaction [Cadmium results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16785314 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased cleavage of PARP1 protein | increases cleavage | 16785314 |
| D019256 | Cadmium Chloride | GLRX protein inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16785314 |
| D019256 | Cadmium Chloride | oxalomalic acid promotes the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16785314 |
| D002166 | Camptothecin | Camptothecin results in increased cleavage of PARP1 protein | increases cleavage | 11741290 15585644 16962673 |
| D002166 | Camptothecin | RBL2 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15585644 |
| D002166 | Camptothecin | THBS1 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16962673 |
| D002211 | Capsaicin | Capsaicin results in increased cleavage of PARP1 protein | increases cleavage | 17505005 |
| C111238 | carboxycinnamic acid bishydroxamide | carboxycinnamic acid bishydroxamide results in increased cleavage of PARP1 protein | increases cleavage | 15897598 |
| D002392 | Catechin | Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16753784 |
| D002392 | Catechin | Catechin results in increased expression of PARP1 protein | increases expression | 16753784 |
| C105934 | celecoxib | celecoxib results in increased cleavage of PARP1 protein | increases cleavage | 16123214 |
| C095591 | chan su | chan su results in increased degradation of PARP1 protein | increases degradation | 16012733 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde analog results in increased cleavage of PARP1 protein | increases cleavage | 16343908 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in increased cleavage of PARP1 protein | increases cleavage | 10741713 |
| D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PARP1 mRNA | affects cotreatment|affects expression | 17602206 |
| D003042 | Cocaine | Cocaine affects the expression of PARP1 mRNA | affects expression | 15681117 |
| D009243 | NAD | PARP1 protein affects the metabolism of and results in increased cleavage of NAD | affects metabolic processing|increases cleavage | 16026317 |
| D003300 | Copper | [Disulfiram binds to Copper] which results in increased cleavage of PARP1 protein | affects binding|increases cleavage | 17079463 |
| C494620 | CPS 11 | CPS 11 results in increased cleavage of PARP1 protein | increases cleavage | 15858615 |
| C494622 | CPS 49 | CPS 49 results in increased cleavage of PARP1 protein | increases cleavage | 15858615 |
| C029892 | cupric chloride | [Disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19789329 |
| D003474 | Curcumin | [Curcumin co-treated with bortezomib] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19372569 |
| D003474 | Curcumin | [Curcumin co-treated with Thalidomide] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19372569 |
| D003474 | Curcumin | Curcumin results in increased cleavage of and results in increased activity of PARP1 protein | increases activity|increases cleavage | 16173963 |
| D003474 | Curcumin | Curcumin results in increased cleavage of PARP1 protein | increases cleavage | 17671742 19235267 18593936 19401701 16023083 14555224 |
| D003474 | Curcumin | [Doxorubicin co-treated with Curcumin] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 18006147 |
| D003474 | Curcumin | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15569404 |
| D003513 | Cycloheximide | Cycloheximide results in increased cleavage of PARP1 protein | increases cleavage | 16051428 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in decreased expression of PARP1 mRNA | decreases expression | 11906922 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased cleavage of PARP1 protein | increases cleavage | 11723234 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of PARP1 mRNA | increases expression | 11599041 |
| C017160 | cypermethrin | cypermethrin inhibits the reaction [Docosahexaenoic Acids results in increased degradation of PARP1 protein] | decreases reaction|increases degradation | 11341974 |
| D003609 | Dactinomycin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14640974 |
| D003609 | Dactinomycin | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14640974 |
| D003609 | Dactinomycin | Dactinomycin results in increased cleavage of PARP1 protein | increases cleavage | 14640974 |
| D003609 | Dactinomycin | PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14640974 |
| D003609 | Dactinomycin | PLD2 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14640974 |
| C014347 | decitabine | [decitabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 18636160 |
| C107676 | deguelin | deguelin inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17015749 |
| C107676 | deguelin | deguelin metabolite results in increased expression of PARP1 protein modified form | increases expression | 19139008 |
| C107676 | deguelin | deguelin results in increased cleavage of PARP1 protein | increases cleavage | 17035597 |
| C107676 | deguelin | deguelin results in increased expression of PARP1 protein modified form | increases expression | 19139008 |
| D015230 | Prostaglandin D2 | Prostaglandin D2 results in increased cleavage of PARP1 protein | increases cleavage | 15843042 |
| C464444 | dehydroxymethylepoxyquinomicin | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15501958 |
| C464444 | dehydroxymethylepoxyquinomicin | dehydroxymethylepoxyquinomicin results in increased cleavage of PARP1 protein | increases cleavage | 15501958 |
| C017185 | delphinidin | delphinidin results in decreased activity of PARP1 protein | decreases activity | 17884996 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16144937 |
| D003907 | Dexamethasone | Dexamethasone results in increased cleavage of PARP1 protein | increases cleavage | 16644695 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16644695 |
| D016190 | Carboplatin | Carboplatin results in increased cleavage of PARP1 protein | increases cleavage | 15996812 |
| C020735 | dibutyldichlorotin | dibutyldichlorotin results in increased cleavage of PARP1 protein | increases cleavage | 16181675 |
| D002945 | Cisplatin | [Cisplatin results in increased activity of CASP3 protein] which results in increased cleavage of PARP1 protein | increases activity|increases cleavage | 18176112 |
| D002945 | Cisplatin | Cisplatin results in increased cleavage of PARP1 protein | increases cleavage | 18071906 16009487 |
| C121718 | dicyclanil | dicyclanil results in decreased expression of PARP1 mRNA | decreases expression | 15664270 |
| C499970 | dideoxypetrosynol A | dideoxypetrosynol A results in increased cleavage of PARP1 protein | increases cleavage | 15547680 |
| D004026 | Dieldrin | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Dieldrin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15183012 |
| D004026 | Dieldrin | Dieldrin results in increased cleavage of PARP1 protein | increases cleavage | 15183012 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PARP1 mRNA | affects cotreatment|affects expression | 17602206 |
| C472511 | dimethylarsinous acid | dimethylarsinous acid inhibits the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein] | decreases reaction|increases activity | 17011244 |
| C472511 | dimethylarsinous acid | dimethylarsinous acid results in decreased activity of PARP1 protein | decreases activity | 17011244 |
| D004221 | Disulfiram | [Disulfiram binds to Copper] which results in increased cleavage of PARP1 protein | affects binding|increases cleavage | 17079463 |
| D004221 | Disulfiram | [Disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19789329 |
| D004221 | Disulfiram | Disulfiram results in increased cleavage of PARP1 protein | increases cleavage | 17079463 |
| C067311 | docetaxel | docetaxel results in increased cleavage of PARP1 protein | increases cleavage | 15970518 |
| D004281 | Docosahexaenoic Acids | cypermethrin inhibits the reaction [Docosahexaenoic Acids results in increased degradation of PARP1 protein] | decreases reaction|increases degradation | 11341974 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased degradation of PARP1 protein | increases degradation | 11341974 |
| D004281 | Docosahexaenoic Acids | tautomycin inhibits the reaction [Docosahexaenoic Acids results in increased degradation of PARP1 protein] | decreases reaction|increases degradation | 11341974 |
| D004298 | Dopamine | Dopamine results in increased cleavage of PARP1 protein | increases cleavage | 15198987 17603292 |
| D004298 | Dopamine | PARK2 protein inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15198987 |
| D004298 | Dopamine | resveratrol inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17603292 |
| D004317 | Doxorubicin | 4-amino-1,8-naphthalimide inhibits the reaction [Doxorubicin results in increased activity of PARP1 protein] | decreases reaction|increases activity | 15456408 |
| D004317 | Doxorubicin | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17285121 |
| D004317 | Doxorubicin | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| D004317 | Doxorubicin | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| D004317 | Doxorubicin | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365 |
| D004317 | Doxorubicin | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365 |
| D004317 | Doxorubicin | Doxorubicin affects the cleavage of PARP1 protein | affects cleavage | 15870702 |
| D004317 | Doxorubicin | Doxorubicin analog results in increased cleavage of PARP1 protein | increases cleavage | 15981920 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 17339365 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 17339365 |
| D004317 | Doxorubicin | Doxorubicin results in increased activity of PARP1 protein | increases activity | 15456408 |
| D004317 | Doxorubicin | Doxorubicin results in increased cleavage of PARP1 protein | increases cleavage | 17285121 16843435 16311509 16962673 17935137 15585644 18281512 18071906 15555623 15557793 17959036 17651020 16890185 |
| D004317 | Doxorubicin | Doxorubicin results in increased degradation of PARP1 protein | increases degradation | 17418594 |
| D004317 | Doxorubicin | DPP4 protein promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15753397 |
| D004317 | Doxorubicin | FASN protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 18281512 |
| D004317 | Doxorubicin | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16311509 |
| D004317 | Doxorubicin | GSTA1 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16890185 |
| D004317 | Doxorubicin | IFNA1 protein promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17959036 |
| D004317 | Doxorubicin | RBL2 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15585644 |
| D004317 | Doxorubicin | SB 203580 inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16843435 |
| D004317 | Doxorubicin | SB 216763 inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| D004317 | Doxorubicin | TGFB1 protein promotes the reaction [Doxorubicin results in increased degradation of PARP1 protein] | increases degradation|increases reaction | 17418594 |
| D004317 | Doxorubicin | THBS1 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16962673 |
| D004317 | Doxorubicin | U 0126 promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15557793 |
| D004317 | Doxorubicin | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17935137 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with Curcumin] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 18006147 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [AZD 6244 results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17876044 |
| D004317 | Doxorubicin | PARP1 gene mutant form inhibits the reaction [Doxorubicin results in increased phosphorylation of CDK2 protein] | decreases reaction|increases phosphorylation | 15861398 |
| D004317 | Doxorubicin | PARP1 gene mutant form promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] | increases activity|increases reaction | 15861398 |
| D004317 | Doxorubicin | PARP1 gene mutant form promotes the reaction [Doxorubicin results in increased activity of CASP7 protein] | increases activity|increases reaction | 15861398 |
| D004317 | Doxorubicin | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BECN1 mRNA] | increases expression|increases reaction | 19001878 |
| D004317 | Doxorubicin | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BECN1 protein] | increases expression|increases reaction | 19001878 |
| D004317 | Doxorubicin | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BNIP3 mRNA] | increases expression|increases reaction | 19001878 |
| D004317 | Doxorubicin | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of CTSB mRNA] | increases expression|increases reaction | 19001878 |
| D004317 | Doxorubicin | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of CTSL mRNA] | increases expression|increases reaction | 19001878 |
| D004317 | Doxorubicin | PARP1 protein results in increased uptake of Doxorubicin | increases uptake | 15861398 |
| D004317 | Doxorubicin | Verapamil inhibits the reaction [PARP1 gene mutant form results in decreased uptake of Doxorubicin] | decreases reaction|decreases uptake | 15861398 |
| D004317 | Doxorubicin | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17285121 |
| D004317 | Doxorubicin | Doxorubicin results in increased cleavage of PARP1 protein | increases cleavage | 17651020 16687611 17285121 |
| D004317 | Doxorubicin | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16687611 |
| D004317 | Doxorubicin | TNF protein promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17651020 |
| C060327 | dracorhodin | dracorhodin analog results in increased cleavage of PARP1 protein | increases cleavage | 15684474 15813022 15215653 16864444 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in increased cleavage of PARP1 protein | increases cleavage | 15802533 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased activity of PARP1 protein | increases activity | 15657356 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased cleavage of PARP1 protein | increases cleavage | 15764647 15705601 |
| C529414 | erigeroflavanone | erigeroflavanone inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 19557877 |
| C007366 | erythritol anhydride | erythritol anhydride results in increased cleavage of PARP1 protein | increases cleavage | 14998682 |
| D000431 | Ethanol | Ethanol results in increased expression of PARP1 mRNA | increases expression | 15353170 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARP1 mRNA | affects cotreatment|increases expression | 17942748 |
| C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | [flavopiridol co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 15634644 |
| D005047 | Etoposide | Etoposide results in increased cleavage of PARP1 protein | increases cleavage | 16844113 17935137 |
| D005047 | Etoposide | HTATIP2 protein promotes the reaction [Etoposide results in increased activity of PARP1 protein] | increases activity|increases reaction | 16799960 |
| D005047 | Etoposide | wortmannin promotes the reaction [Etoposide results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17935137 |
| C049639 | evodiamine | evodiamine promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15710601 |
| C017875 | fisetin | fisetin results in decreased activity of PARP1 protein | decreases activity | 17884996 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of PARP1 mRNA | decreases expression | 15465739 |
| D005419 | Flavonoids | Flavonoids results in increased expression of PARP1 mRNA | increases expression | 18035473 |
| C077990 | flavopiridol | BCL2 protein mutant form inhibits the reaction [flavopiridol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 12170773 |
| C077990 | flavopiridol | [flavopiridol co-treated with 7-hydroxystaurosporine] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 16012789 |
| C077990 | flavopiridol | [flavopiridol co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 15634644 |
| C077990 | flavopiridol | [flavopiridol co-treated with gemcitabine] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 15770523 |
| C077990 | flavopiridol | flavopiridol results in increased cleavage of PARP1 protein | increases cleavage | 15972445 12517783 12170773 |
| C007738 | fluoranthene | fluoranthene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [gambogic acid results in decreased expression of PARP1 mRNA] | decreases expression|increases reaction | 19084572 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 19084572 |
| D005472 | Fluorouracil | Fluorouracil results in increased cleavage of PARP1 protein | increases cleavage | 16525653 15996812 17982676 |
| D005472 | Fluorouracil | TP53 protein promotes the reaction [Fluorouracil results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17982676 |
| D005492 | Folic Acid | Folic Acid results in increased cleavage of PARP1 protein | increases cleavage | 16728583 |
| C052659 | gambogic acid | Fluorouracil promotes the reaction [gambogic acid results in decreased expression of PARP1 mRNA] | decreases expression|increases reaction | 19084572 |
| C052659 | gambogic acid | Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 19084572 |
| C052659 | gambogic acid | gambogic acid results in decreased expression of PARP1 mRNA | decreases expression | 19084572 |
| C052659 | gambogic acid | gambogic acid results in increased cleavage of PARP1 protein | increases cleavage | 19084572 |
| C054597 | garcinol | garcinol results in increased cleavage of PARP1 protein | increases cleavage | 16052481 |
| C419708 | gefitinib | gefitinib affects the reaction [oxaliplatin results in increased cleavage of PARP1 protein] | affects reaction|increases cleavage | 16243822 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16311509 |
| C001277 | geldanamycin | geldanamycin results in increased degradation of PARP1 protein | increases degradation | 17293044 |
| C001277 | geldanamycin | Tretinoin inhibits the reaction [geldanamycin results in increased degradation of PARP1 protein] | decreases reaction|increases degradation | 17293044 |
| C056507 | gemcitabine | benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [gemcitabine results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17146438 |
| C056507 | gemcitabine | [flavopiridol co-treated with gemcitabine] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 15770523 |
| C056507 | gemcitabine | gemcitabine results in increased cleavage of PARP1 protein | increases cleavage | 17146438 |
| D005978 | Glutathione | Glutathione deficiency promotes the reaction [antimony trioxide results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16112521 |
| D005978 | Glutathione | Glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14660655 |
| C059922 | gossypetin | gossypetin results in decreased activity of PARP1 protein | decreases activity | 17884996 |
| C482862 | heyneanol A | heyneanol A results in increased cleavage of PARP1 protein | increases cleavage | 16675471 |
| C005499 | honokiol | honokiol results in increased cleavage of PARP1 protein | increases cleavage | 15802533 |
| D017313 | Fenretinide | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| D017313 | Fenretinide | Ascorbic Acid inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| D017313 | Fenretinide | bisindolylmaleimide I inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| D017313 | Fenretinide | Butylated Hydroxyanisole inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| D017313 | Fenretinide | Fenretinide affects the expression of PARP1 mRNA | affects expression | 16570282 |
| D017313 | Fenretinide | [Fenretinide co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 17273769 |
| D017313 | Fenretinide | Fenretinide promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16230421 |
| D017313 | Fenretinide | Fenretinide results in decreased cleavage of PARP1 protein | decreases cleavage | 17159502 |
| D017313 | Fenretinide | Fenretinide results in increased cleavage of PARP1 protein | increases cleavage | 15735044 16407847 |
| D017313 | Fenretinide | MAPK8 protein promotes the reaction [Fenretinide results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16407847 |
| D017313 | Fenretinide | PD 169316 inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| D017313 | Fenretinide | PD 98059 inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| C479128 | HS 1200 | HS 1200 results in increased degradation of PARP1 protein | increases degradation | 12969788 |
| D006830 | Hydralazine | [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP1 mRNA | affects cotreatment|increases expression | 17183730 |
| D006861 | Hydrogen Peroxide | dimethylarsinous acid inhibits the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein] | decreases reaction|increases activity | 17011244 |
| D006861 | Hydrogen Peroxide | monomethylarsonous acid inhibits the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein] | decreases reaction|increases activity | 17011244 |
| D006861 | Hydrogen Peroxide | PARP1 protein affects the susceptibility to Hydrogen Peroxide | affects response to substance | 19111594 |
| D006861 | Hydrogen Peroxide | [sodium arsenite co-treated with Hydrogen Peroxide] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 18977016 |
| D006861 | Hydrogen Peroxide | erigeroflavanone inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 19557877 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased cleavage of PARP1 protein | increases cleavage | 19557877 15876423 |
| D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15876423 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased degradation of PARP1 protein | increases degradation | 16157298 |
| C041508 | indeno(1,2,3-cd)pyrene | indeno(1,2,3-cd)pyrene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C016517 | indole-3-carbinol | indole-3-carbinol promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15811958 |
| D007213 | Indomethacin | Indomethacin promotes the reaction [LTA protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17873517 |
| D007213 | Indomethacin | Indomethacin results in increased cleavage of PARP1 protein | increases cleavage | 15804060 15812552 12663503 |
| C506002 | ircinin-1 | ircinin-1 results in increased cleavage of PARP1 protein | increases cleavage | 16163705 |
| C510621 | KCC 009 | KCC 009 results in increased cleavage of PARP1 protein | increases cleavage | 16170020 |
| C048341 | mafosfamide | BCL2 protein inhibits the reaction [mafosfamide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 11723234 |
| C048341 | mafosfamide | mafosfamide results in increased cleavage of PARP1 protein | increases cleavage | 11723234 |
| C065861 | malvidin | malvidin results in increased cleavage of PARP1 protein | increases cleavage | 15964118 |
| D008727 | Methotrexate | Methotrexate results in increased cleavage of PARP1 protein | increases cleavage | 17286800 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased cleavage of PARP1 protein | increases cleavage | 17363558 |
| C020771 | methylmercury hydroxide | methylmercury hydroxide results in increased expression of PARP1 mRNA | increases expression | 20493249 |
| D008741 | Methyl Methanesulfonate | PARP1 protein affects the susceptibility to Methyl Methanesulfonate | affects response to substance | 19111594 |
| D008770 | Methylnitrosourea | PARP1 gene mutant form results in increased susceptibility to Methylnitrosourea | increases response to substance | 15282315 |
| D008770 | Methylnitrosourea | PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein] | affects activity|affects reaction | 11850828 |
| D008770 | Methylnitrosourea | PARP1 protein affects the reaction [Methylnitrosourea affects the expression of TRP53 protein] | affects expression|affects reaction | 11850828 |
| D008770 | Methylnitrosourea | PARP1 protein affects the susceptibility to Methylnitrosourea | affects response to substance | 11850828 |
| D008770 | Methylnitrosourea | PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] | affects metabolic processing|increases reaction | 16052507 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased activity of PARP1 protein | increases activity | 16168987 |
| D008770 | Methylnitrosourea | Niacinamide inhibits the reaction [Methylnitrosourea results in increased activity of PARP1 protein] | decreases reaction|increases activity | 16168987 |
| C008493 | methylselenic acid | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| C008493 | methylselenic acid | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365 |
| C008493 | methylselenic acid | [Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 17339365 |
| C008493 | methylselenic acid | HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16204082 |
| C008493 | methylselenic acid | methylselenic acid results in increased cleavage of PARP1 protein | increases cleavage | 16204082 15845651 |
| C008493 | methylselenic acid | SB 216763 inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| C008493 | methylselenic acid | methylselenic acid results in increased cleavage of PARP1 protein | increases cleavage | 19276161 |
| D014290 | Metipranolol | Metipranolol inhibits the reaction [Zinc results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| D014290 | Metipranolol | Metipranolol inhibits the reaction [Zinc Sulfate results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| D015735 | Mifepristone | Mifepristone results in increased cleavage of PARP1 protein | increases cleavage | 16525653 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16644695 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid inhibits the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein] | decreases reaction|increases activity | 17011244 |
| D009151 | Mustard Gas | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Mustard Gas results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 12482751 |
| D009151 | Mustard Gas | CALM1 protein promotes the reaction [Mustard Gas results in increased cleavage of and results in increased activity of PARP1 protein] | increases activity|increases cleavage|increases reaction | 16935404 |
| D009151 | Mustard Gas | FADD protein affects the reaction [Mustard Gas results in increased cleavage of PARP1 protein] | affects reaction|increases cleavage | 12482751 |
| D009151 | Mustard Gas | Mustard Gas promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 12482751 |
| D009151 | Mustard Gas | Mustard Gas results in increased cleavage of and results in increased activity of PARP1 protein | increases activity|increases cleavage | 16935404 |
| D009151 | Mustard Gas | Mustard Gas results in increased cleavage of PARP1 protein | increases cleavage | 11886524 17229443 12482751 |
| D009151 | Mustard Gas | PARP1 protein affects the reaction [Mustard Gas affects the activity of CASP3 protein] | affects activity|affects reaction | 11886524 |
| D009151 | Mustard Gas | PARP1 protein inhibits the reaction [Mustard Gas results in increased activity of CASP3 protein] | decreases reaction|increases activity | 11886524 |
| C040015 | myricetin | myricetin results in decreased activity of PARP1 protein | decreases activity | 17884996 |
| C040015 | myricetin | myricetin results in increased cleavage of PARP1 protein | increases cleavage | 15748703 |
| D009537 | Nicotinamide Mononucleotide | PARP1 protein affects the abundance of Nicotinamide Mononucleotide | affects abundance | 19426698 |
| D009569 | Nitric Oxide | Nitric Oxide results in increased cleavage of PARP1 protein | increases cleavage | 16024610 15126337 |
| C434926 | N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride | N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased activity of PARP1 protein | decreases activity | 17884996 |
| C514334 | NSC606985 | NSC606985 results in increased cleavage of PARP1 protein | increases cleavage | 19747914 |
| C122062 | NSC 674495 | PARP1 protein affects the susceptibility to NSC 674495 | affects response to substance | 17674193 |
| C404397 | NSC 680410 | NSC 680410 results in increased degradation of PARP1 protein | increases degradation | 14647418 |
| D019301 | Oleic Acid | Oleic Acid results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| D019319 | Okadaic Acid | Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage|increases reaction | 16059913 |
| C011959 | oridonin | oridonin results in increased cleavage of PARP1 protein | increases cleavage | 16019488 |
| C055122 | orlistat | [orlistat co-treated with Thapsigargin] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 17283163 |
| C055122 | orlistat | orlistat results in increased cleavage of PARP1 protein | increases cleavage | 17283163 |
| C030110 | oxaliplatin | gefitinib affects the reaction [oxaliplatin results in increased cleavage of PARP1 protein] | affects reaction|increases cleavage | 16243822 |
| C030110 | oxaliplatin | oxaliplatin results in increased cleavage of PARP1 protein | increases cleavage | 16243822 |
| C015407 | oxalomalic acid | oxalomalic acid promotes the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16785314 |
| C015407 | oxalomalic acid | oxalomalic acid promotes the reaction [Cadmium results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16785314 |
| D010100 | Oxygen | Oxygen deficiency results in increased cleavage of PARP1 protein | increases cleavage | 11042672 |
| D010100 | Oxygen | Phenylephrine inhibits the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 11042672 |
| D017239 | Paclitaxel | Paclitaxel results in increased cleavage of PARP1 protein | increases cleavage | 15585644 18071906 |
| D017239 | Paclitaxel | [resveratrol co-treated with Paclitaxel] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 14749477 |
| C019248 | pamidronate | pamidronate results in increased cleavage of PARP1 protein | increases cleavage | 10780527 |
| C482884 | panduratin A | panduratin A results in increased cleavage of PARP1 protein | increases cleavage | 16497706 |
| D010269 | Paraquat | [Antimycin A co-treated with Paraquat] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 16237197 |
| D010269 | Paraquat | Paraquat results in increased cleavage of PARP1 protein | increases cleavage | 17018646 |
| D010269 | Paraquat | [pyridaben co-treated with Paraquat] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 16237197 |
| C408604 | PD 169316 | PD 169316 inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16407847 |
| C031181 | phenanthrene | phenanthrene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C040601 | phenanthridone | phenanthridone results in decreased activity of PARP1 protein | decreases activity | 14769338 |
| D010656 | Phenylephrine | Phenylephrine inhibits the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 11042672 |
| C012491 | phytosphingosine | phytosphingosine results in increased activity of PARP1 protein | increases activity | 15486061 |
| C121565 | pifithrin | pifithrin inhibits the reaction [silybin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16777994 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16687611 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of PARP1 mRNA | increases expression | 18301758 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of PARP1 mRNA | decreases expression | 16940010 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of PARP1 mRNA | decreases expression | 15465739 |
| D010936 | Plant Extracts | Plant Extracts results in increased cleavage of PARP1 protein | increases cleavage | 19168119 17619071 |
| D028321 | Plant Preparations | Plant Preparations results in increased cleavage of PARP1 protein | increases cleavage | 15369734 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C025299 | polyphenols | polyphenols results in decreased expression of PARP1 mRNA | decreases expression | 15465739 |
| D011353 | Prodigiosin | Prodigiosin results in increased cleavage of PARP1 protein | increases cleavage | 15746575 |
| C030984 | pyrene | pyrene results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C428725 | pyridaben | [pyridaben co-treated with Paraquat] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 16237197 |
| C428725 | pyridaben | pyridaben results in increased cleavage of PARP1 protein | increases cleavage | 16237197 |
| D011794 | Quercetin | Quercetin metabolite results in increased expression of PARP1 protein | increases expression | 16280456 |
| D011794 | Quercetin | Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 18377872 17876056 |
| D011794 | Quercetin | Quercetin results in decreased activity of PARP1 protein | decreases activity | 17884996 |
| D011794 | Quercetin | Quercetin results in increased cleavage of PARP1 protein | increases cleavage | 15741050 18787224 |
| D011794 | Quercetin | Quercetin results in increased degradation of PARP1 protein | increases degradation | 16059641 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15876423 |
| D011794 | Quercetin | Quercetin results in decreased expression of PARP1 protein | decreases expression | 17039455 |
| D011804 | Quinolines | Quinolines analog results in increased cleavage of PARP1 protein | increases cleavage | 15826604 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased cleavage of PARP1 protein | increases cleavage | 16412576 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 19631782 |
| C059514 | resveratrol | [resveratrol co-treated with Paclitaxel] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 14749477 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Dopamine results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17603292 |
| C059514 | resveratrol | resveratrol inhibits the reaction [IL1B protein results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 17404069 17959154 |
| C059514 | resveratrol | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17823925 |
| C059514 | resveratrol | [resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PARP1 protein | decreases activity|increases activity | 16628003 |
| C059514 | resveratrol | resveratrol results in increased cleavage of PARP1 protein | increases cleavage | 17164350 17007014 16814113 16617056 17554206 17534123 19631782 |
| C059514 | resveratrol | vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage | 19631782 |
| C059514 | resveratrol | resveratrol results in increased cleavage of PARP1 protein | increases cleavage | 17872969 16675471 |
| D012402 | Rotenone | ATG5 protein affects the reaction [Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]] | affects reaction|decreases reaction|increases cleavage | 19682553 |
| D012402 | Rotenone | Rotenone results in increased cleavage of PARP1 protein | increases cleavage | 19682553 |
| D012402 | Rotenone | Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 19682553 |
| C039961 | S-(1,2-dichlorovinyl)cysteine | S-(1,2-dichlorovinyl)cysteine results in increased cleavage of PARP1 protein | increases cleavage | 15967204 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16328441 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16843435 |
| C417521 | SB 216763 | SB 216763 inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| C524947 | Scutellaria barbata extract | Scutellaria barbata extract results in increased cleavage of PARP1 protein | increases cleavage | 15369734 |
| D012642 | Selegiline | Selegiline inhibits the reaction [3-morpholino-sydnonimine results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 12880480 |
| D012643 | Selenium | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| D012643 | Selenium | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365 |
| D012643 | Selenium | [Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 17339365 |
| C040115 | shogaol | Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 18384088 |
| C040115 | shogaol | shogaol results in increased cleavage of PARP1 protein | increases cleavage | 18384088 |
| C440975 | silybin | pifithrin inhibits the reaction [silybin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16777994 |
| C440975 | silybin | silybin results in increased cleavage of and results in increased activity of PARP1 protein | increases activity|increases cleavage | 16777994 |
| D012838 | Silymarin | Silymarin results in increased cleavage of PARP1 protein | increases cleavage | 19168119 |
| D020123 | Sirolimus | ATG5 protein affects the reaction [Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]] | affects reaction|decreases reaction|increases cleavage | 19682553 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 19682553 |
| C025473 | sitosterol | sitosterol results in increased cleavage of PARP1 protein | increases cleavage | 14612938 |
| C017947 | sodium arsenite | BLVRA protein inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15741166 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with FASLG protein] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 18977016 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Hydrogen Peroxide] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 18977016 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Vitamin K 3] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19082730 |
| C017947 | sodium arsenite | sodium arsenite results in decreased activity of PARP1 protein | decreases activity | 20036271 19056730 |
| C017947 | sodium arsenite | sodium arsenite results in increased cleavage of PARP1 protein | increases cleavage | 15741166 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of PARP1 protein | increases expression | 20036271 |
| C017947 | sodium arsenite | zinc chloride inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein] | decreases activity|decreases reaction | 19056730 |
| C017947 | sodium arsenite | GADD45A protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16973625 |
| C017947 | sodium arsenite | MAPK8 protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16973625 |
| C017947 | sodium arsenite | MAPK9 protein promotes the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16973625 |
| C017947 | sodium arsenite | PARP1 gene mutant form results in increased susceptibility to sodium arsenite | increases response to substance | 16322246 |
| C017947 | sodium arsenite | sodium arsenite results in increased cleavage of PARP1 protein | increases cleavage | 16973625 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased cleavage of PARP1 protein | increases cleavage | 15845651 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of PARP1 mRNA | increases expression | 18175754 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased activity of PARP1 protein | decreases activity | 18209489 |
| C091861 | spermine nitric oxide complex | spermine nitric oxide complex results in increased cleavage of PARP1 protein | increases cleavage | 16024610 |
| C518872 | SRM 1597 | SRM 1597 results in increased cleavage of PARP1 protein | increases cleavage | 21132278 |
| C013690 | styrene oxide | styrene oxide results in increased cleavage of PARP1 protein | increases cleavage | 11929631 |
| C013690 | styrene oxide | styrene oxide results in increased cleavage of PARP1 protein | increases cleavage | 17662326 |
| D013449 | Sulfonamides | Sulfonamides analog results in increased cleavage of PARP1 protein | increases cleavage | 15826604 |
| D013467 | Sulindac | Sulindac results in increased activity of PARP1 protein | increases activity | 15713900 |
| C025462 | sulindac sulfide | sulindac sulfide results in decreased expression of PARP1 mRNA | decreases expression | 16184548 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased cleavage of PARP1 protein | increases cleavage | 12663503 18678619 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased cleavage of PARP1 protein | increases cleavage | 16886631 |
| D013629 | Tamoxifen | alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 14645110 |
| D013629 | Tamoxifen | Tamoxifen results in increased cleavage of PARP1 protein | increases cleavage | 14645110 |
| C053079 | tautomycin | tautomycin inhibits the reaction [Docosahexaenoic Acids results in increased degradation of PARP1 protein] | decreases reaction|increases degradation | 11341974 |
| D013745 | Tetanus Toxoid | Tetanus Toxoid results in increased cleavage of PARP1 protein | increases cleavage | 17286800 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PARP1 mRNA | affects cotreatment|increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PARP1 mRNA | increases expression | 19465110 |
| D013792 | Thalidomide | [Curcumin co-treated with Thalidomide] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19372569 |
| D013792 | Thalidomide | Thalidomide analog results in increased cleavage of PARP1 protein | increases cleavage | 15858615 |
| D019284 | Thapsigargin | [orlistat co-treated with Thapsigargin] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 17283163 |
| D014212 | Tretinoin | LTF protein inhibits the reaction [Tretinoin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 16168621 |
| D014212 | Tretinoin | Tretinoin results in increased cleavage of PARP1 protein | increases cleavage | 16168621 |
| D014212 | Tretinoin | [IFNB1 protein co-treated with Tretinoin] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 16826196 |
| D014212 | Tretinoin | Tretinoin inhibits the reaction [geldanamycin results in increased degradation of PARP1 protein] | decreases reaction|increases degradation | 17293044 |
| D014212 | Tretinoin | Tretinoin results in increased cleavage of PARP1 protein | increases cleavage | 17387344 |
| C469689 | tricetin | tricetin results in decreased activity of PARP1 protein | decreases activity | 17884996 |
| C012589 | trichostatin A | trichostatin A results in increased cleavage of PARP1 protein | increases cleavage | 17431121 |
| C012589 | trichostatin A | trichostatin A results in increased degradation of PARP1 protein | increases degradation | 16010430 |
| C012589 | trichostatin A | [trichostatin A results in increased expression of GDF15 protein] which results in increased cleavage of PARP1 protein | increases cleavage|increases expression | 18801729 |
| C037718 | trimethyltin hydroxide | trimethyltin hydroxide results in increased cleavage of PARP1 protein | increases cleavage | 16181675 |
| C001899 | triptolide | triptolide results in increased cleavage of PARP1 protein | increases cleavage | 15972136 |
| C113580 | U 0126 | U 0126 promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 15557793 |
| C113580 | U 0126 | U 0126 results in increased cleavage of PARP1 protein | increases cleavage | 15557793 |
| C005466 | ursolic acid | ursolic acid results in increased cleavage of PARP1 protein | increases cleavage | 16012738 |
| D014635 | Valproic Acid | [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP1 mRNA | affects cotreatment|increases expression | 17183730 |
| D014700 | Verapamil | Verapamil inhibits the reaction [PARP1 gene mutant form results in decreased uptake of Doxorubicin] | decreases reaction|decreases uptake | 15861398 |
| D009536 | Niacinamide | Niacinamide inhibits the reaction [Methylnitrosourea results in increased activity of PARP1 protein] | decreases reaction|increases activity | 16168987 |
| D009536 | Niacinamide | PARP1 protein affects the chemical synthesis of Niacinamide | affects chemical synthesis | 16026317 |
| D014810 | Vitamin E | Vitamin E results in increased expression of PARP1 mRNA | increases expression | 19244175 |
| D024483 | Vitamin K 3 | [sodium arsenite co-treated with Vitamin K 3] results in increased cleavage of PARP1 protein | affects cotreatment|increases cleavage | 19082730 |
| C111237 | vorinostat | [bortezomib co-treated with vorinostat] results in increased degradation of PARP1 protein | affects cotreatment|increases degradation | 12893773 |
| C111237 | vorinostat | vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage | 19631782 |
| C111237 | vorinostat | vorinostat promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 16377638 |
| C111237 | vorinostat | vorinostat results in increased cleavage of PARP1 protein | increases cleavage | 19631782 17431121 15897598 |
| C009687 | wortmannin | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17935137 |
| C009687 | wortmannin | wortmannin promotes the reaction [Etoposide results in increased cleavage of PARP1 protein] | increases cleavage|increases reaction | 17935137 |
| C519885 | WP1066 | WP1066 results in increased cleavage of PARP1 protein | increases cleavage | 18245540 18056455 |
| C451735 | WP 744 | WP 744 results in increased cleavage of PARP1 protein | increases cleavage | 15555623 |
| C104536 | xanthohumol | xanthohumol results in increased cleavage of PARP1 protein | increases cleavage | 15995977 |
| D015018 | Ytterbium | Ytterbium analog results in increased cleavage of PARP1 protein | increases cleavage | 19632212 |
| C403304 | zerumbone | zerumbone results in increased cleavage of PARP1 protein | increases cleavage | 16007145 |
| D015032 | Zinc | Zinc results in increased cleavage of PARP1 protein | increases cleavage | 16472982 16799065 |
| D015032 | Zinc | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| D015032 | Zinc | Metipranolol inhibits the reaction [Zinc results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| D015032 | Zinc | Zinc results in decreased expression of PARP1 protein | decreases expression | 16799065 |
| C016837 | zinc chloride | zinc chloride inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein] | decreases activity|decreases reaction | 19056730 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased cleavage of PARP1 protein | increases cleavage | 16799065 |
| D019287 | Zinc Sulfate | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc Sulfate results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| D019287 | Zinc Sulfate | Metipranolol inhibits the reaction [Zinc Sulfate results in decreased expression of PARP1 protein] | decreases expression|decreases reaction | 16799065 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in decreased expression of PARP1 protein | decreases expression | 16799065 |
| C088658 | zoledronic acid | zoledronic acid results in increased cleavage of PARP1 protein | increases cleavage | 10780527 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 8.62 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 8.62 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 4-amino-2,6-dinitrotoluene | 24.51 | 7525203 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 24.51 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 24.51 | 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 24.51 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 24.51 | 12039119 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 24.51 | 15322242 11752688 14514962 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 24.51 | 8333272 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 24.51 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 2.72 | 19490988 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.98 | 15043669 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 10.38 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 10.38 | 11192467 | |
| MESH:D000138 | Acidosis | Zinc Sulfate | 10.38 | 7265320 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 2.62 | 17505938 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 4.27 | 9207937 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.20 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 4.09 | 16889938 17190629 17202136 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 22.06 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 22.06 | 12690470 15814532 17670903 | |
| MESH:D058186 | Acute Kidney Injury | Folic Acid | 22.06 | 16316344 16595132 17003819 | |
| MESH:D058186 | Acute Kidney Injury | pifithrin | 22.06 | 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 22.06 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 22.06 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 22.06 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 11.91 | 20525806 21297076 | |
| MESH:D055371 | Acute Lung Injury | Bleomycin | 11.91 | 17118201 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 11.91 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 11.91 | 18653653 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 4.17 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 27.97 | 17363558 | |
| MESH:D000230 | Adenocarcinoma | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 27.97 | 15831436 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 27.97 | 11798837 19825857 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 27.97 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 27.97 | 11798837 17638652 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 27.97 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | dracorhodin | 27.97 | 15215653 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 27.97 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 27.97 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 27.97 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 27.97 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 27.97 | 15688392 15113128 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 27.97 | 11910360 | |
| MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 17.26 | 3712494 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 17.26 | 6695378 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 17.26 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Folic Acid | 17.26 | 16963246 | |
| MESH:D000236 | Adenoma | Indomethacin | 17.26 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 17.26 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 17.26 | 10223192 | |
| MESH:D018248 | Adenoma, Liver Cell | 3,4,5,3',4'-pentachlorobiphenyl | 19.17 | 16628245 | |
| MESH:D018248 | Adenoma, Liver Cell | dicyclanil | 19.17 | 17162532 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 19.17 | 16434500 19061943 18056438 19052882 17162532 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 19.17 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 19.17 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 6.38 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 6.38 | 17611924 11535846 16460482 12394442 19003578 11874996 15623613 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.37 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 3.57 | 16712894 17306315 | |
| MESH:D000382 | Agricultural Workers' Diseases | cypermethrin | 4.98 | 16487989 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 4.98 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 3.28 | 21441931 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.99 | 15451039 15451040 | |
| MESH:D000437 | Alcoholism | Disulfiram | 3.87 | 10841824 17079463 18968458 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.75 | 17887948 | |
| MESH:D000505 | Alopecia | Capsaicin | 5.83 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 5.83 | 15955085 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.04 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 17.75 | 17570602 14715435 15207723 | |
| MESH:D000544 | Alzheimer Disease | Copper | 17.75 | 17119284 16886094 16410023 16962711 16325427 16866297 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 17.75 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Folic Acid | 17.75 | 17116317 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 17.75 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 17.75 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 17.75 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 17.75 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 17.75 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 17.75 | 16410023 16580781 16325427 17119284 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 3.90 | 17688650 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 7.73 | 10965797 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 7.73 | 10694572 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 7.73 | 16510725 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 8.12 | 15504547 17963324 | |
| MESH:D000740 | Anemia | Fluorouracil | 8.12 | 17963324 16511603 15504547 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 8.12 | 11748828 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.26 | 11369114 17661222 14761424 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.03 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 3.69 | 16614410 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.64 | 16916123 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 4.10 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.52 | 10982225 | |
| MESH:D000853 | Anophthalmos | Benomyl | 8.16 | 15907663 | |
| MESH:D000853 | Anophthalmos | Ethanol | 8.16 | 15513904 | |
| MESH:D000860 | Anoxia | Bleomycin | 16.11 | 15782499 | |
| MESH:D000860 | Anoxia | Oleic Acid | 16.11 | 15090967 | |
| MESH:D000860 | Anoxia | Oxygen | 16.11 | 20872349 | |
| MESH:D000860 | Anoxia | Zinc Sulfate | 16.11 | 7265320 | |
| MESH:D000881 | Anthrax | Ciprofloxacin | 5.38 | 20385868 | |
| MESH:D016736 | Antiphospholipid Syndrome | Ciprofloxacin | 5.38 | 9485080 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.63 | 15043669 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 5.26 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 5.26 | 17497229 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 3.58 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 7.45 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 7.45 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 2.96 | 17460149 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 9.87 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 9.87 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 9.87 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.84 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 16.08 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 16.08 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 16.08 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 16.08 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 16.08 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 16.08 | 16412693 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.43 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 5.81 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 5.81 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 5.81 | 17286800 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 5.81 | 16292516 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 5.84 | 16516891 | |
| MESH:D001249 | Asthma | Mustard Gas | 5.84 | 10378619 | |
| MESH:D001249 | Asthma | Tretinoin | 5.84 | 16456186 | |
| MESH:D001249 | Asthma | Zinc | 5.84 | 17085522 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 3.66 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 10.51 | 17363696 16126721 16037261 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 10.51 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 10.51 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 10.51 | 16391483 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 10.51 | 16873680 17967414 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 3.08 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Arachidonic Acid | 3.08 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Docosahexaenoic Acids | 3.08 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Folic Acid | 3.08 | 21388746 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 3.08 | 16917939 19056591 18929414 19267885 | |
| MESH:D001321 | Autistic Disorder | Sirolimus | 3.08 | 21115397 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 3.08 | 15238991 19460635 18316065 17157402 20603192 18177632 17507914 18940202 18775368 16609825 17688650 18558336 19232924 18985861 18396377 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 10.82 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 10.82 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 10.82 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Ciprofloxacin | 4.58 | 11505790 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.13 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 3.69 | 10684365 | |
| MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 3.68 | 1440618 11289319 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 2.22 | 20046352 17594078 | |
| MESH:D001768 | Blister | Mustard Gas | 3.84 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 12.13 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 12.13 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 12.13 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 12.13 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.47 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 4.66 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 4.66 | 8888407 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.90 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 18.58 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 18.58 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 18.58 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 18.58 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 6.73 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 6.73 | 17312309 16121404 15867366 16778634 11697798 19442620 | |
| MESH:D001862 | Bone Resorption | Berberine | 12.98 | 9881647 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 12.98 | 9881647 | |
| MESH:D001862 | Bone Resorption | pamidronate | 12.98 | 8053405 15845617 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 12.98 | 18496637 16769263 18404659 15845617 8053405 11869084 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 4.03 | 11207687 | |
| MESH:D001919 | Bradycardia | Capsaicin | 6.61 | 18207255 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 6.61 | 15306635 | |
| MESH:D001929 | Brain Edema | Indomethacin | 3.70 | 11481608 | |
| MESH:D001930 | Brain Injuries | Zinc | 3.41 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 18.20 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 18.20 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 18.20 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 18.20 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 18.20 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Copper | 14.96 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 14.96 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 14.96 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 14.96 | 16187019 | |
| MESH:D001932 | Brain Neoplasms | KCC 009 | 14.96 | 16170020 | |
| MESH:D001943 | Breast Neoplasms | 2-methoxyestradiol-3,17-bis-O,O-sulfamate | 51.06 | 17426705 12711022 12711013 17957467 15862969 14970876 | |
| MESH:D001943 | Breast Neoplasms | 4-(1H-imidazol-1-yl)retinoic acid | 51.06 | 17145897 17387344 | |
| MESH:D001943 | Breast Neoplasms | alitretinoin | 51.06 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 51.06 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | bendamustine | 51.06 | 17667603 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 51.06 | 17162533 11921183 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 51.06 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 51.06 | 18382427 19526202 | |
| MESH:D001943 | Breast Neoplasms | Copper | 51.06 | 17079463 15986119 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 51.06 | 19250217 18593918 18462866 16243823 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 51.06 | 17020986 11325840 15136595 17388661 15093573 18323546 16978400 18234424 12006526 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 51.06 | 19208741 18320071 | |
| MESH:D001943 | Breast Neoplasms | deguelin | 51.06 | 18593368 17035597 | |
| MESH:D001943 | Breast Neoplasms | Dieldrin | 51.06 | 11859874 15770527 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 51.06 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Disulfiram | 51.06 | 17026967 | |
| MESH:D001943 | Breast Neoplasms | docetaxel | 51.06 | 16264153 16495393 18628466 19526202 15567936 15692762 17369602 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 51.06 | 11325840 16115903 16264153 16826403 19526202 15567936 18628466 15668708 16096432 15994142 17983394 17426702 17369602 15993339 15939500 18382427 18695136 18234424 16595493 16322301 16935488 15634643 15136595 15692762 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 51.06 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 51.06 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | flavopiridol | 51.06 | 12517783 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 51.06 | 15136595 18357371 16595493 19217205 18608205 16110121 16557594 | |
| MESH:D001943 | Breast Neoplasms | Folic Acid | 51.06 | 16777985 | |
| MESH:D001943 | Breast Neoplasms | gemcitabine | 51.06 | 17039268 18382427 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 51.06 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 51.06 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | Methotrexate | 51.06 | 16978400 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 51.06 | 16253758 14633655 11306469 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 51.06 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 51.06 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 51.06 | 18234424 16273361 11325840 15136595 18223236 18323546 16115903 16244791 | |
| MESH:D001943 | Breast Neoplasms | Plant Preparations | 51.06 | 17398067 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 51.06 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Quinolines | 51.06 | 16273361 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 51.06 | 17651959 16393696 17534123 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 51.06 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 51.06 | 15668708 17893378 17242785 18997820 20859285 16818667 21138602 20135344 19059307 11161223 17049068 19155303 20390343 18351453 21152245 19221464 19410462 18855134 18425577 16273361 19487384 20065188 16873071 19011961 19200415 19115204 19289846 18821012 17440819 18629630 19288272 16202921 19103187 20544844 20005174 19189212 18984771 19244106 19084267 19189210 17261762 19066611 19142967 18815881 15565566 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 51.06 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 51.06 | 16873071 16443354 16166294 | |
| MESH:D001943 | Breast Neoplasms | vorinostat | 51.06 | 16144943 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 51.06 | 18695136 16096432 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.84 | 15286001 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 3.65 | 17687719 10378619 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.28 | 16813970 | |
| MESH:D019121 | Burkholderia Infections | orlistat | 5.30 | 17874328 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.08 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 7.13 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 7.13 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 4.01 | 9625245 | |
| MESH:D002100 | Cachexia | Indomethacin | 3.70 | 15141370 15625704 11239499 16537180 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.21 | 16962696 | |
| MESH:D002177 | Candidiasis | Disulfiram | 4.54 | 15325261 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 2.67 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 7.96 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 7.96 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 10.86 | 18593918 | |
| MESH:D002277 | Carcinoma | Disulfiram | 10.86 | 17026967 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 10.86 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 10.86 | 16835633 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.21 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.82 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 48.25 | 3581430 7296757 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 48.25 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 48.25 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 48.25 | 16217749 11135700 14691202 15553829 15073043 | |
| MESH:D006528 | Carcinoma, Hepatocellular | AZD 6244 | 48.25 | 17876044 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 48.25 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 48.25 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | deguelin | 48.25 | 18575727 | |
| MESH:D006528 | Carcinoma, Hepatocellular | dicyclanil | 48.25 | 17162532 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 48.25 | 18056438 20524982 16502159 20512989 3084413 21159647 10672840 16830150 18691550 16540662 20727157 16288022 19052882 18506893 20214788 20935162 19701751 19107877 19208518 17428255 19919837 17978847 19418558 19383236 18665156 18494052 10737359 19822196 18210153 17138121 16569478 19171122 16328049 16779866 20432363 11831363 18393292 19335982 17055752 20101231 16935385 19394651 16878318 18978308 18971187 3581430 16681979 20084675 20514400 17162532 17761372 16698587 18788625 20007298 19539802 19519916 17173139 16807293 18785209 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 48.25 | 18059187 16234567 17876044 16023760 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 48.25 | 18788625 15763234 15289165 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 48.25 | 16270382 17159502 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 48.25 | 17971768 16332177 17045692 17088986 16799960 18930000 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 48.25 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 48.25 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 48.25 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 48.25 | 19519916 12508355 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 48.25 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Sirolimus | 48.25 | 19335982 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 48.25 | 16507464 15276417 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 48.25 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 48.25 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 48.25 | 1917145 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 16.75 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | heyneanol A | 16.75 | 16675471 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 16.75 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 16.75 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.04 | 14736730 11352223 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 23.62 | 16179969 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 23.62 | 16052434 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 23.62 | 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 23.62 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 23.62 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 23.62 | 17026967 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | docetaxel | 23.62 | 11894018 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | gefitinib | 23.62 | 15496427 19233551 20005069 17290066 18347146 16230376 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 23.62 | 12391285 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 23.62 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.66 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.54 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 17.52 | 7296757 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 17.52 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 17.52 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 17.52 | 1485588 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 17.52 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 17.52 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 17.52 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.92 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 45.45 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 45.45 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Bleomycin | 45.45 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 45.45 | 6189445 17066447 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 45.45 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 45.45 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 45.45 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | erythritol anhydride | 45.45 | 10925838 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 45.45 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 45.45 | 17066447 16280240 16757204 18986760 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 45.45 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 45.45 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Plant Preparations | 45.45 | 17418620 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 45.45 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Sirolimus | 45.45 | 19435901 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 45.45 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 45.45 | 16096774 16051514 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 45.45 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Amiloride | 9.37 | 14644129 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Ciprofloxacin | 9.37 | 15028437 10741713 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 9.37 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Copper | 14.84 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 14.84 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 14.84 | 15728586 16170337 17287366 17124262 11754973 11179087 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 14.84 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 14.84 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 14.84 | 18670907 18850075 16120746 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 2.55 | 16612575 17131338 16242529 18627295 15811867 16364871 17007740 17329180 17928571 17351982 16269455 16651473 16455267 15476868 16952015 17519947 17382496 16731534 15792986 17308081 16109756 17974986 16278810 17924179 15505089 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 2.31 | 16243910 17334414 | |
| MESH:D002318 | Cardiovascular Diseases | Folic Acid | 11.85 | 16755160 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 11.85 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | Plant Preparations | 11.85 | 16862667 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 11.85 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 11.85 | 16936243 | |
| MESH:D016893 | Carotid Stenosis | Plant Preparations | 4.82 | 15158307 | |
| MESH:D002386 | Cataract | 4-amino-2,6-dinitrotoluene | 13.12 | 14694615 | |
| MESH:D002386 | Cataract | Acetaminophen | 13.12 | 10977129 | |
| MESH:D002386 | Cataract | Disulfiram | 13.12 | 15003327 17936468 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 13.12 | 12484553 | |
| MESH:D002386 | Cataract | Tretinoin | 13.12 | 17460283 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 19.38 | 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 19.38 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 19.38 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 19.38 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 19.38 | 2727394 21159647 7505956 17174075 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 19.38 | 7505956 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 19.38 | 19716837 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 19.38 | 19524636 20056578 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 8.63 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 8.63 | 16129372 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 2.05 | 20734317 | |
| MESH:D018281 | Cholangiocarcinoma | 3,4,5,3',4'-pentachlorobiphenyl | 13.63 | 16628245 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 13.63 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 13.63 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 13.63 | 18291259 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.84 | 11181007 | |
| MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 10.45 | 9022650 19486331 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 10.45 | 17333356 15861022 17681005 16105132 17110522 16919318 11677210 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 10.45 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 10.45 | 19176532 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.82 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.46 | 15894690 | |
| MESH:D002916 | Chylothorax | orlistat | 5.30 | 17003701 | |
| MESH:D002971 | Cleft Lip | Ethanol | 4.88 | 15513904 | |
| MESH:D002971 | Cleft Lip | Folic Acid | 4.88 | 21254359 | |
| MESH:D002972 | Cleft Palate | Ethanol | 7.55 | 15513904 | |
| MESH:D002972 | Cleft Palate | Folic Acid | 7.55 | 8946559 21254359 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 7.55 | 16354765 15668235 8697196 15340226 12621046 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 7.55 | 9407595 | |
| MESH:D019970 | Cocaine-Related Disorders | Cocaine | 8.36 | 19606084 | |
| MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 8.36 | 19462300 | |
| MESH:D003092 | Colitis | Amiloride | 20.99 | 12065299 | |
| MESH:D003092 | Colitis | Curcumin | 20.99 | 16782535 16804969 18200517 | |
| MESH:D003092 | Colitis | resveratrol | 20.99 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 20.99 | 17936198 | |
| MESH:D003092 | Colitis | Thalidomide | 20.99 | 16680017 | |
| MESH:D003092 | Colitis | Tretinoin | 20.99 | 17035595 | |
| MESH:D003093 | Colitis, Ulcerative | Mesalamine | 4.52 | 17339853 | |
| MESH:D003103 | Coloboma | Curcumin | 3.33 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | 2'-benzoyloxycinnamaldehyde | 29.17 | 14660655 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 29.17 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 29.17 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 29.17 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 29.17 | 17510524 16343908 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 29.17 | 16340194 19359593 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 29.17 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 29.17 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 29.17 | 17169374 15001691 17172411 17725105 18772588 16510598 17016597 17018589 16340194 17287894 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 29.17 | 15963497 11260862 15625704 15936596 15786552 15637740 | |
| MESH:D003110 | Colonic Neoplasms | oxaliplatin | 29.17 | 16510598 16004971 16024531 | |
| MESH:D003110 | Colonic Neoplasms | polyphenols | 29.17 | 16293270 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 29.17 | 17191121 19440933 19056647 11134977 17148506 16640504 15741050 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 29.17 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 29.17 | 12902858 12458338 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 21.95 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 21.95 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 21.95 | 18349538 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 21.95 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 21.95 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 21.95 | 18259882 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 21.95 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 21.95 | 17695437 14970324 18509181 17016601 16303861 15148649 16391804 17594712 16282729 17094418 20501625 15289873 16524972 18448328 18383874 18949393 18802399 18288408 17454858 17401013 16331619 17255274 | |
| MESH:D015179 | Colorectal Neoplasms | Folic Acid | 21.95 | 16963246 16985020 17087956 17116713 17245555 | |
| MESH:D015179 | Colorectal Neoplasms | gefitinib | 21.95 | 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 21.95 | 18059344 11197048 12606626 17054584 | |
| MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 21.95 | 17695437 17594712 18509181 17255274 18448328 17401013 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 21.95 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 21.95 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 21.95 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 21.95 | 10666051 11197048 18059344 11076880 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 4.15 | 17323712 | |
| MESH:D000013 | Congenital Abnormalities | 4-amino-2,6-dinitrotoluene | 5.32 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 5.32 | 14669216 17141729 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 8.34 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 8.34 | 9301478 | |
| MESH:D003324 | Coronary Artery Disease | Plant Preparations | 3.33 | 15158307 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.76 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.93 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.38 | 17302372 | |
| MESH:D003371 | Cough | Capsaicin | 3.86 | 10350223 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.97 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | 3,4,5,3',4'-pentachlorobiphenyl | 17.37 | 17686920 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 17.37 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 17.37 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 17.37 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 17.37 | 15451040 11198716 15513904 15451039 10194807 19302082 11873399 | |
| MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 17.37 | 12039119 9562676 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 17.37 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 17.37 | 15322242 20055451 10048152 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 17.37 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 17.37 | 9211117 10589399 9142499 17551590 16925845 8800419 14991402 9125849 9224671 9664655 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 17.37 | 17688650 8888407 16575769 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 17.37 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 17.37 | 19302082 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.33 | 16078585 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 14.33 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Ciprofloxacin | 14.33 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Docosahexaenoic Acids | 14.33 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 14.33 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Methotrexate | 14.33 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 7.70 | 12161096 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 7.70 | 18372110 18433785 12161096 12913760 15276878 18710439 12388444 18093676 11948286 17010015 18483878 15643279 17979934 16614059 18295254 16651033 16989017 10498854 10700343 16413132 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.48 | 16733453 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.86 | 15213294 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.64 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.07 | 19031437 | |
| MESH:D003872 | Dermatitis | Benzene | 3.49 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 4.82 | 14531868 11298694 8156756 11906362 2524372 8970840 12868966 18759878 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 4.82 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 4.82 | 12438553 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.63 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 2.28 | 3621924 2952479 | |
| MESH:D003882 | Dermatomyositis | Methotrexate | 3.86 | 20191521 | |
| MESH:D048909 | Diabetes Complications | erigeroflavanone | 8.86 | 19557877 | |
| MESH:D048909 | Diabetes Complications | orlistat | 8.86 | 19207292 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 5.52 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 5.52 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 7.50 | 11751995 10990075 15331540 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 7.50 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 7.50 | 16873680 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 2.64 | 18772604 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | alpha-Tocopherol | 16.85 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 16.85 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 16.85 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 16.85 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 16.85 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 16.85 | 16886840 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Niacinamide | 16.85 | 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Quinolines | 16.85 | 17400452 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 16.85 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 12.01 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 12.01 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 12.01 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 12.01 | 19279558 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 3.91 | 17621415 12861449 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 9.04 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 9.04 | 7907874 7237001 | |
| MESH:D003967 | Diarrhea | orlistat | 9.04 | 20002075 | |
| MESH:D003967 | Diarrhea | vorinostat | 9.04 | 20479100 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 27.48 | 16192314 6482804 7440962 9653073 18289764 18692083 6679447 8291058 9328219 9022650 1440618 11289319 18648102 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4-amino-2,6-dinitrotoluene | 27.48 | 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 27.48 | 19416960 12705907 16781746 19164858 19370779 12958197 11529661 16109766 10774834 17906064 11743745 18071297 12153990 15619225 17562736 15968718 14725611 19085960 19923254 16177239 2444490 16227642 14550746 10915739 16393943 11287661 12540782 12594235 10663392 16081117 11461765 17522070 19739265 11421492 12392966 19420014 16485898 11834606 11739529 14986274 18713872 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 27.48 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 27.48 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 27.48 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 27.48 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 27.48 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | NAD | 27.48 | 11461765 | |
| MESH:D056486 | Drug-Induced Liver Injury | polyphenols | 27.48 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 27.48 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Silymarin | 27.48 | 14998559 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 27.48 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 27.48 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 27.48 | 1733752 19641884 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.77 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 10.83 | 19839026 15033597 12649298 12231392 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 10.83 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Plant Preparations | 10.83 | 11033412 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 10.83 | 11462148 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 3.84 | 18446180 16133044 18043480 12774134 16326151 17190690 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 8.33 | 11535926 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 8.33 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 8.33 | 16699067 17351913 17151854 11595431 17329845 17202747 11535926 11595415 11991626 10671773 17045617 | |
| MESH:D004417 | Dyspnea | cypermethrin | 6.61 | 16487989 | |
| MESH:D004417 | Dyspnea | Oxygen | 6.61 | 20016425 | |
| MESH:D004421 | Dystonia | Valproic Acid | 2.82 | 1851702 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 8.67 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin E | 8.67 | 9068938 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.21 | 12438553 | |
| MESH:D004487 | Edema | Arachidonic Acid | 24.20 | 9599246 15177302 9831321 16716910 7990266 11698051 | |
| MESH:D004487 | Edema | bisindolylmaleimide I | 24.20 | 8273558 | |
| MESH:D004487 | Edema | Bleomycin | 24.20 | 17118201 | |
| MESH:D004487 | Edema | Dexamethasone | 24.20 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 24.20 | 8985016 16100529 10653021 7907874 8273558 7990266 19703484 | |
| MESH:D004487 | Edema | Mustard Gas | 24.20 | 11402378 11428647 11428631 9260866 | |
| MESH:D004487 | Edema | pirinixic acid | 24.20 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 24.20 | 12787963 | |
| MESH:D004487 | Edema | resveratrol | 24.20 | 8985016 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 24.20 | 12711302 11000095 | |
| MESH:D004489 | Edema, Cardiac | 3,4,5,3',4'-pentachlorobiphenyl | 13.49 | 17686920 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 13.49 | 15322242 16714409 18230668 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 13.49 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 11.85 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 11.85 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 11.85 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 11.85 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 9.62 | 19294695 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 9.62 | 19294695 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 9.54 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Folic Acid | 9.54 | 17301261 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 9.54 | 20544844 17893378 16202921 19155303 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 9.54 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 16.25 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 16.25 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 16.25 | 16134523 | |
| MESH:D004715 | Endometriosis | Sulindac | 16.25 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 16.25 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 9.65 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 9.65 | 15268973 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 3.21 | 18509659 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.43 | 10567023 16328016 17763956 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 8.10 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 8.10 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 5.07 | 11006010 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 5.07 | 11298111 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 2.88 | 3659116 17275665 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 2.62 | 3922381 16628512 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 4.05 | 19439326 19700373 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 4.05 | 18234410 20417680 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 2.45 | 6426943 6254150 7562514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 3.01 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 2.77 | 3659116 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.84 | 9357497 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.78 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 4.39 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 25.52 | 3581430 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 25.52 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 25.52 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 25.52 | 16481741 16785472 15464296 17638652 15173087 | |
| MESH:D004938 | Esophageal Neoplasms | docetaxel | 25.52 | 16337965 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 25.52 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 25.52 | 16481741 15173087 17638652 16337965 16785472 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 25.52 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 25.52 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Plant Preparations | 25.52 | 16510608 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 25.52 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 25.52 | 16543248 | |
| MESH:D017889 | Exfoliation Syndrome | Folic Acid | 4.18 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Benomyl | 9.08 | 1914497 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 9.08 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 9.08 | 16938888 9664655 | |
| MESH:D005221 | Fatigue | vorinostat | 4.29 | 20479100 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 30.44 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 30.44 | 18296743 | |
| MESH:D005234 | Fatty Liver | Curcumin | 30.44 | 19297423 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 30.44 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Ethanol | 30.44 | 19236843 18620774 16409862 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 30.44 | 15345470 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 30.44 | 20131406 19236843 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 30.44 | 15975614 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 30.44 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 30.44 | 19224547 14986274 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.33 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.27 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.51 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.98 | 15451040 10194807 16946407 15513904 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.18 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 3.55 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 2.87 | 18558336 8888407 | |
| MESH:D005334 | Fever | Arachidonic Acid | 5.67 | 11852909 | |
| MESH:D005334 | Fever | Indomethacin | 5.67 | 17627676 11852909 10431976 | |
| MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 3.68 | 6705139 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 8.61 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 8.61 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 12.05 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 12.05 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 12.05 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 7.87 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 7.87 | 11555667 | |
| MESH:D005355 | Fibrosis | arsenite | 18.38 | 18296743 | |
| MESH:D005355 | Fibrosis | Curcumin | 18.38 | 18705752 | |
| MESH:D005355 | Fibrosis | Indomethacin | 18.38 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 18.38 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 18.38 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 18.38 | 17994277 | |
| MESH:D005414 | Flatulence | orlistat | 5.30 | 20002075 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.84 | 11298111 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.00 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 3.90 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 22.24 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 22.24 | 15046732 | |
| MESH:D005756 | Gastritis | Folic Acid | 22.24 | 17171786 | |
| MESH:D005756 | Gastritis | Indomethacin | 22.24 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 22.24 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.75 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.41 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 3.37 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.97 | 12701121 | |
| MESH:D005901 | Glaucoma | Folic Acid | 3.84 | 16504073 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 33.19 | 18405923 | |
| MESH:D005909 | Glioblastoma | Curcumin | 33.19 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 33.19 | 17150277 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 33.19 | 16187019 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 33.19 | 12870263 | |
| MESH:D005909 | Glioblastoma | KCC 009 | 33.19 | 16170020 | |
| MESH:D005909 | Glioblastoma | myricetin | 33.19 | 19804834 | |
| MESH:D005909 | Glioblastoma | Okadaic Acid | 33.19 | 17312396 | |
| MESH:D005909 | Glioblastoma | Quercetin | 33.19 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 33.19 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 33.19 | 18801729 | |
| MESH:D005910 | Glioma | Fluorouracil | 10.37 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 10.37 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 10.37 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 10.37 | 17643826 | |
| MESH:D005910 | Glioma | Thalidomide | 10.37 | 16327979 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.20 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.83 | 11124998 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.16 | 11849393 | |
| MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 2.79 | 7505956 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.26 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 4.04 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 7.90 | 11014644 16376943 15172196 | |
| MESH:D006086 | Graft vs Host Disease | Methotrexate | 7.90 | 16518429 | |
| MESH:D006130 | Growth Disorders | Amiloride | 5.66 | 19703807 | |
| MESH:D006130 | Growth Disorders | Zinc | 5.66 | 17217573 | |
| MESH:D006261 | Headache | Nitric Oxide | 3.87 | 11554966 11284996 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 24.67 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 24.67 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 24.67 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 24.67 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 24.67 | 18337622 15102660 15162350 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 24.67 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Sirolimus | 24.67 | 19435901 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 24.67 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 3.13 | 19898482 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.82 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.26 | 15464296 | |
| MESH:D006356 | Heartburn | Capsaicin | 4.39 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | 3,4,5,3',4'-pentachlorobiphenyl | 21.48 | 20471113 17686920 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 21.48 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 21.48 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | benzo(k)fluoranthene | 21.48 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Folic Acid | 21.48 | 17286298 16524890 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 21.48 | 11294989 10048152 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 21.48 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 21.48 | 16080930 | |
| MESH:D006331 | Heart Diseases | Ciprofloxacin | 7.07 | 11505790 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 7.07 | 16707910 14766674 18006777 16495754 17875725 16244372 17888722 16879835 16244371 16330681 12587719 16144979 18674790 | |
| MESH:D006331 | Heart Diseases | pifithrin | 7.07 | 14766674 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 11.85 | 17481944 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 11.85 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 11.85 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 11.85 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 11.85 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.43 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Ciprofloxacin | 6.91 | 17643012 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 6.91 | 17241300 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 2.72 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 3.42 | 16183116 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 4.00 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.13 | 11000095 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.35 | 15633222 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 4.20 | 14986274 | |
| MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 8.82 | 6705139 | |
| MESH:D006505 | Hepatitis | cypermethrin | 8.82 | 16487989 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 8.82 | 18339527 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.42 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 3.96 | 17338147 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 11.28 | 17182432 17109627 17276780 16607473 19888908 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 11.28 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 11.28 | 17063115 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 4.11 | 19772884 16221962 19176532 18467677 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 4.11 | 12621046 16120746 15340226 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.75 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 5.48 | 16863852 16490937 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 5.48 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 5.48 | 16490937 16863852 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 9.13 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 9.13 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 9.13 | 16876885 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 2.86 | 12878215 | |
| MESH:D006679 | HIV Seropositivity | Folic Acid | 4.18 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Bleomycin | 13.96 | 15147373 17606976 18501091 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 13.96 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 13.96 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 13.96 | 18501091 17606976 15147373 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 13.96 | 16135485 16200630 18180244 17606976 15147373 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 13.96 | 12676792 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 6.06 | 17454163 16566672 14716179 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 6.06 | 14716179 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 3.55 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.72 | 15340226 18606429 8697196 16959395 16354765 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 19.90 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 19.90 | 17434803 17043245 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 19.90 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 19.90 | 12727271 | |
| MESH:D006930 | Hyperalgesia | oxaliplatin | 19.90 | 17418472 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 19.90 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 19.90 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.38 | 17883296 | |
| MESH:D006934 | Hypercalcemia | bortezomib | 7.40 | 18089816 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 7.40 | 18089816 19622757 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 5.40 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 5.40 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 8.38 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 8.38 | 11156591 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.28 | 16778211 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 5.31 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 5.31 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Catechin | 9.03 | 17292331 | |
| MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 9.03 | 16397167 16395265 16755160 16865747 16433478 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 9.03 | 16484555 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 16.04 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | orlistat | 16.04 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 16.04 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 16.04 | 16873680 | |
| MESH:D006949 | Hyperlipidemias | ursolic acid | 16.04 | 8847885 | |
| MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 2.66 | 15034207 | |
| MESH:D006973 | Hypertension | Amiloride | 13.40 | 19344079 18524855 15174897 | |
| MESH:D006973 | Hypertension | Benzene | 13.40 | 17940673 | |
| MESH:D006973 | Hypertension | Dexamethasone | 13.40 | 17042910 | |
| MESH:D006973 | Hypertension | Phenylephrine | 13.40 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Quercetin | 13.40 | 18356687 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 13.40 | 18850075 18670907 | |
| MESH:D006973 | Hypertension | Verapamil | 13.40 | 17700361 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Hydralazine | 3.34 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | gefitinib | 5.39 | 18424623 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 5.39 | 15838368 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 6.98 | 18502941 12791704 | |
| MESH:D006984 | Hypertrophy | Sirolimus | 6.98 | 19211884 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 3.11 | 17488730 | |
| MESH:D017380 | Hypertrophy, Right Ventricular | gefitinib | 4.92 | 18424623 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.86 | 12669777 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Amiloride | 4.54 | 19822448 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 2.53 | 16569931 16945680 | |
| MESH:D007022 | Hypotension | Dopamine | 5.79 | 6740701 | |
| MESH:D007022 | Hypotension | Zinc Sulfate | 5.79 | 7265320 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.70 | 10574470 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 4.04 | 10647630 16133968 10651667 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 4.00 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 4.04 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | pifithrin | 7.69 | 19475672 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 7.69 | 17600658 | |
| MESH:D007247 | Infertility, Female | Dieldrin | 6.20 | 10630421 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 6.20 | 12013081 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 13.33 | 16517039 7193160 | |
| MESH:D007248 | Infertility, Male | decitabine | 13.33 | 17581917 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 13.33 | 17937319 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 13.33 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 13.33 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 13.33 | 15346721 12646999 | |
| MESH:D007249 | Inflammation | Amiloride | 52.50 | 17237260 | |
| MESH:D007249 | Inflammation | Arachidonic Acid | 52.50 | 17371808 15177302 9831321 | |
| MESH:D007249 | Inflammation | bisindolylmaleimide I | 52.50 | 8273558 | |
| MESH:D007249 | Inflammation | Bleomycin | 52.50 | 17118201 | |
| MESH:D007249 | Inflammation | Capsaicin | 52.50 | 16956363 | |
| MESH:D007249 | Inflammation | Curcumin | 52.50 | 18403477 16956363 17151092 | |
| MESH:D007249 | Inflammation | Dexamethasone | 52.50 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 52.50 | 18785209 | |
| MESH:D007249 | Inflammation | Flavonoids | 52.50 | 17296493 | |
| MESH:D007249 | Inflammation | honokiol | 52.50 | 19539808 | |
| MESH:D007249 | Inflammation | Indomethacin | 52.50 | 7812673 12568917 3291741 | |
| MESH:D007249 | Inflammation | Mustard Gas | 52.50 | 17524151 11428647 9357497 11428631 11428620 11402378 8975870 9260866 16001271 | |
| MESH:D007249 | Inflammation | Plant Extracts | 52.50 | 12787963 15997105 16366677 19332304 | |
| MESH:D007249 | Inflammation | polyphenols | 52.50 | 16366677 | |
| MESH:D007249 | Inflammation | resveratrol | 52.50 | 16366677 | |
| MESH:D007249 | Inflammation | Silymarin | 52.50 | 17213517 | |
| MESH:D007249 | Inflammation | Sulindac | 52.50 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 52.50 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 52.50 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Thalidomide | 52.50 | 16134734 | |
| MESH:D007249 | Inflammation | ursolic acid | 52.50 | 8847885 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.49 | 18596194 18200517 | |
| MESH:D007251 | Influenza, Human | Quercetin | 15.93 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 15.93 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 15.93 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 15.93 | 16624496 | |
| MESH:D007299 | Insect Bites and Stings | cypermethrin | 4.65 | 15189238 | |
| MESH:D007333 | Insulin Resistance | Berberine | 9.52 | 18563319 | |
| MESH:D007333 | Insulin Resistance | orlistat | 9.52 | 17201808 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 9.52 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 9.52 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 9.25 | 11855677 10210152 15831440 11686837 17329856 11713966 15610444 17994277 18236018 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 9.25 | 11574821 11713966 10210152 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 9.25 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 9.70 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 9.70 | 12584176 12351151 12628509 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 9.70 | 12351151 10213222 12628509 12584176 12663524 10223192 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 3.75 | 11245490 12394442 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 3.83 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 4.04 | 15241188 | |
| MESH:D007511 | Ischemia | Zinc | 3.36 | 16584753 | |
| MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 3.68 | 8074119 9022650 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 10.19 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 10.19 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 10.19 | 17551590 15992940 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.70 | 18306037 10574470 16133968 | |
| MESH:D007627 | Keloid | Quercetin | 3.66 | 17086741 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.32 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.81 | 15464296 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 27.15 | 15629191 12587719 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 27.15 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 27.15 | 16322080 16226777 16962696 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 27.15 | 16962696 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 27.15 | 18289764 15190930 12649298 19839026 12231392 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 27.15 | 15369732 16775033 15699352 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 27.15 | 17190690 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 27.15 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 27.15 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 27.15 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Zinc | 27.15 | 16960431 | |
| MESH:C531755 | Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules | orlistat | 5.30 | 17185156 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 18.58 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 18.58 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 18.58 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 18.58 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 18.58 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 8.67 | 6582329 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 8.67 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | gefitinib | 8.67 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 8.67 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.47 | 11231351 | |
| MESH:D007805 | Language Development Disorders | Methotrexate | 3.86 | 9562676 | |
| MESH:D007859 | Learning Disorders | Copper | 5.85 | 17134702 | |
| MESH:D007859 | Learning Disorders | Ethanol | 5.85 | 15451040 | |
| MESH:D007889 | Leiomyoma | Curcumin | 3.33 | 18555241 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 3.52 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 5.05 | 10320625 11703811 12228301 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 5.05 | 15237267 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 3.30 | 16514283 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 19.64 | 12970779 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 19.64 | 15070760 | |
| MESH:D007938 | Leukemia | Benzene | 19.64 | 17119257 18335105 14694614 15935818 | |
| MESH:D007938 | Leukemia | Curcumin | 19.64 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 19.64 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 19.64 | 18980019 19235587 | |
| MESH:D007938 | Leukemia | Quercetin | 19.64 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 19.64 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.82 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | bendamustine | 11.33 | 18980985 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 11.33 | 17658394 18587576 17802794 17296974 18172266 17008537 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 11.33 | 17026967 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 11.33 | 15802533 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | honokiol | 11.33 | 15802533 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 17.71 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 17.71 | 18089816 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 17.71 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Docosahexaenoic Acids | 17.71 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 17.71 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 17.52 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 17.52 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 17.52 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 17.52 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 7.89 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 7.89 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 7.89 | 16572323 10785260 15631656 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 13.00 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 13.00 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 13.00 | 17236224 19117987 18454857 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 13.00 | 16482212 16932348 19285840 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 14.96 | 19850784 17050201 16968895 20471514 16467208 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 14.96 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 14.96 | 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 14.96 | 18460780 18206229 17679729 18704418 19010910 19387464 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 14.96 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 14.96 | 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 14.96 | 17596541 16294345 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 14.96 | 18206229 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 14.96 | 16294345 17596541 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.13 | 18055864 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | antimony trioxide | 13.24 | 9834237 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 13.24 | 17107899 16331271 11468182 17869043 19035177 19075265 17217047 16966277 16823087 15748426 16112521 12679006 19642359 15336539 17649720 12018890 9834237 16330433 17712046 16891316 12712474 19225113 15213294 15622746 11161223 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | dracorhodin | 13.24 | 16864444 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 13.24 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 13.24 | 17649720 19029980 16766008 19225113 16331271 16140955 19035177 17301526 16823087 17361223 17294898 17368321 17339181 16935935 17712046 17217047 15748426 16891316 19642359 17506722 16788101 12679006 17107899 19075265 9834237 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.52 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.52 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 4.04 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.38 | 17980183 | |
| MESH:D007970 | Leukopenia | Ciprofloxacin | 7.85 | 17846019 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 7.85 | 11830472 10052129 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.71 | 16707609 | |
| MESH:D056929 | Liddle Syndrome | Amiloride | 4.68 | 19344079 | |
| MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 14.39 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 14.39 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 14.39 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 14.39 | 10473037 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 14.39 | 9224671 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 2.13 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.58 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.38 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 24.12 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 24.12 | 19638242 18522880 18407596 18665156 20032147 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 24.12 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 24.12 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Methotrexate | 24.12 | 14986274 | |
| MESH:D008103 | Liver Cirrhosis | orlistat | 24.12 | 17404856 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 24.12 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Silymarin | 24.12 | 17213517 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 24.12 | 16943688 17174718 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.78 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 5.19 | 15034207 9327722 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 5.19 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 27.62 | 17355460 18705752 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 27.62 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 27.62 | 16439617 16595196 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 27.62 | 15818738 15864749 12632512 15763062 18606216 17881167 18567088 17666798 18371158 15849816 16610055 17348192 15754396 15641146 15383259 17036385 15744066 17629604 15339415 18237412 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 27.62 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 27.62 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 27.62 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 27.62 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 27.62 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Preparations | 27.62 | 17724770 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 27.62 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | silybin | 27.62 | 16169303 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Silymarin | 27.62 | 15754394 17198567 18277467 15864749 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Sirolimus | 27.62 | 17050028 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 27.62 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 27.62 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 27.62 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 27.62 | 18397230 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 27.62 | 16169303 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 24.85 | 19014921 19784758 19460945 12969438 11587558 16611625 16610002 12587719 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 24.85 | 16956363 | |
| MESH:D008107 | Liver Diseases | Curcumin | 24.85 | 16956363 | |
| MESH:D008107 | Liver Diseases | cypermethrin | 24.85 | 15991261 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 24.85 | 17034775 | |
| MESH:D008107 | Liver Diseases | Docosahexaenoic Acids | 24.85 | 17056761 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 24.85 | 17207593 | |
| MESH:D008107 | Liver Diseases | Folic Acid | 24.85 | 16877991 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 24.85 | 17034775 | |
| MESH:D008107 | Liver Diseases | polyphenols | 24.85 | 16698588 | |
| MESH:D008107 | Liver Diseases | Silymarin | 24.85 | 17213517 | |
| MESH:D008107 | Liver Diseases | Sulfonamides | 24.85 | 14986274 | |
| MESH:D008107 | Liver Diseases | Sulindac | 24.85 | 14986274 16867024 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 7.58 | 17347304 17207112 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Silymarin | 7.58 | 17213517 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 2.06 | 16871587 17185352 | |
| MESH:D008113 | Liver Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 44.48 | 16835634 18644402 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 44.48 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 44.48 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | Clofibric Acid | 44.48 | 17602206 | |
| MESH:D008113 | Liver Neoplasms | Copper | 44.48 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | dicyclanil | 44.48 | 20118626 | |
| MESH:D008113 | Liver Neoplasms | Dieldrin | 44.48 | 9539021 8742319 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 44.48 | 20101389 21047994 18648771 19996281 20452335 19256749 19090486 19073162 19254457 19690152 19499222 20434301 18978307 19833225 19551842 19427195 19638242 9163691 21071580 21278145 19294768 19850985 19812893 19426721 20118626 20583210 15175105 15885732 18644402 12112319 19642983 20137499 18977376 12771043 2862719 16942905 18754104 20492335 2422723 10737359 20501860 21167192 20405173 19255062 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 44.48 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 44.48 | 16603448 17045692 15113037 18383874 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 44.48 | 15890375 20007298 16377806 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 44.48 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 44.48 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 44.48 | 19321006 19812893 20405173 19073162 | |
| MESH:D008113 | Liver Neoplasms | Silymarin | 44.48 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 44.48 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 44.48 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 44.48 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 44.48 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 19.15 | 3712494 6587162 598648 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 19.15 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 19.15 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 19.15 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 19.15 | 9362446 3124819 19004024 18253720 18079962 17854601 18775883 18093689 2563599 19519916 17174075 19126423 19539802 21159647 16267830 16842330 19009564 18282651 18544905 18164116 17942915 18308698 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 19.15 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 19.15 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | styrene oxide | 19.15 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 19.15 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.29 | 15213294 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 4.17 | 16080182 | |
| MESH:D008171 | Lung Diseases | 2-chloroethyl ethyl sulfide | 19.14 | 16252256 18675330 12815614 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 19.14 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 19.14 | 11504702 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 19.14 | 16863852 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 19.14 | 18161513 18702808 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 19.14 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 19.14 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 11.59 | 14698565 | |
| MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 11.59 | 18516814 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 11.59 | 17228818 | |
| MESH:D055370 | Lung Injury | Ciprofloxacin | 11.49 | 18197910 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 11.49 | 11395602 | |
| MESH:D055370 | Lung Injury | Oleic Acid | 11.49 | 15090967 | |
| MESH:D055370 | Lung Injury | Oxygen | 11.49 | 18339021 | |
| MESH:D008175 | Lung Neoplasms | 9-deoxy-delta-9-prostaglandin D2 | 58.14 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 58.14 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | alpha-Tocopherol | 58.14 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 58.14 | 19825857 11798837 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 58.14 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 58.14 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 58.14 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 58.14 | 20869020 20464547 6695378 18520028 20135361 18569708 18816296 17053015 20064080 | |
| MESH:D008175 | Lung Neoplasms | Bleomycin | 58.14 | 6189445 | |
| MESH:D008175 | Lung Neoplasms | Ciprofloxacin | 58.14 | 20211752 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 58.14 | 17225452 11798837 6189445 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 58.14 | 18462866 19359593 16243823 | |
| MESH:D008175 | Lung Neoplasms | deguelin | 58.14 | 19336726 16288123 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 58.14 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 58.14 | 6695378 20970405 20512841 21163286 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 58.14 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 58.14 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 58.14 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 58.14 | 16537180 11497255 11053908 | |
| MESH:D008175 | Lung Neoplasms | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | 58.14 | 17363558 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 58.14 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 58.14 | 3148597 8781369 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 58.14 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Polycyclic Hydrocarbons, Aromatic | 58.14 | 10814675 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 58.14 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | silybin | 58.14 | 16788158 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 58.14 | 16712894 17077188 17306315 15276417 19931552 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 58.14 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 58.14 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 58.14 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 58.14 | 11062179 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.48 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 2.80 | 17718048 | |
| MESH:D008207 | Lymphatic Metastasis | orlistat | 4.61 | 18770866 20805790 | |
| MESH:D008223 | Lymphoma | Benzene | 30.76 | 17119257 17584886 | |
| MESH:D008223 | Lymphoma | bortezomib | 30.76 | 16098063 | |
| MESH:D008223 | Lymphoma | Curcumin | 30.76 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 30.76 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 30.76 | 19470736 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 30.76 | 16098063 | |
| MESH:D008223 | Lymphoma | Etoposide | 30.76 | 12854902 12556972 | |
| MESH:D008223 | Lymphoma | Methotrexate | 30.76 | 17352296 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 30.76 | 11418001 16257854 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 30.76 | 16166326 | |
| MESH:D016393 | Lymphoma, B-Cell | bortezomib | 19.15 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 19.15 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 19.15 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 19.15 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 19.15 | 14737004 | |
| MESH:D020522 | Lymphoma, Mantle-Cell | bendamustine | 5.01 | 18980985 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 11.42 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 11.42 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 11.42 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 11.42 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 12.23 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 12.23 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 12.23 | 15621674 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | vorinostat | 4.40 | 20479100 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 9.37 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 9.37 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 9.37 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 28.61 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 28.61 | 19196722 12104042 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 28.61 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 28.61 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 28.61 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | gefitinib | 28.61 | 18375820 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 28.61 | 16051031 11807958 19196723 15688392 14633655 15113128 16827153 10767621 14999141 15313902 17020996 11751437 17131329 16944150 16619500 10838139 12931682 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 28.61 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 28.61 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 28.61 | 11731420 16827153 19196722 19196723 14580682 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 28.61 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 28.61 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 3.22 | 19453300 | |
| MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 4.38 | 16832597 | |
| MESH:D008527 | Medulloblastoma | bortezomib | 4.34 | 19213072 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 4.34 | 17453147 | |
| MESH:D008545 | Melanoma | 2-methoxyestradiol-3,17-bis-O,O-sulfamate | 54.55 | 14970876 | |
| MESH:D008545 | Melanoma | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 54.55 | 17992120 | |
| MESH:D008545 | Melanoma | Bleomycin | 54.55 | 15577320 | |
| MESH:D008545 | Melanoma | Carboplatin | 54.55 | 11712820 16342250 12040289 16225601 | |
| MESH:D008545 | Melanoma | Cisplatin | 54.55 | 16432458 12393984 17023156 18505091 16248763 12883367 16809738 11135225 15577323 18176117 17761969 18332650 12374674 | |
| MESH:D008545 | Melanoma | Curcumin | 54.55 | 17885582 18462866 | |
| MESH:D008545 | Melanoma | decitabine | 54.55 | 17785578 16505122 | |
| MESH:D008545 | Melanoma | Disulfiram | 54.55 | 15367699 | |
| MESH:D008545 | Melanoma | docetaxel | 54.55 | 12417787 | |
| MESH:D008545 | Melanoma | Doxorubicin | 54.55 | 16827129 | |
| MESH:D008545 | Melanoma | dracorhodin | 54.55 | 15684474 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 54.55 | 17992120 11746506 | |
| MESH:D008545 | Melanoma | Fenretinide | 54.55 | 16270382 | |
| MESH:D008545 | Melanoma | orlistat | 54.55 | 20805790 18770866 | |
| MESH:D008545 | Melanoma | Paclitaxel | 54.55 | 12025231 16342250 12040289 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 54.55 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 54.55 | 17992120 | |
| MESH:D008545 | Melanoma | Sirolimus | 54.55 | 19282848 | |
| MESH:D008545 | Melanoma | sodium arsenite | 54.55 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Sulindac | 54.55 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 54.55 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Thalidomide | 54.55 | 17089043 12829675 16098027 | |
| MESH:D008545 | Melanoma | Tretinoin | 54.55 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 54.55 | 16505122 | |
| MESH:D008545 | Melanoma | Vitamin K 3 | 54.55 | 19082730 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 7.18 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 7.18 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 11.11 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 11.11 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 11.11 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 5.62 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 5.62 | 18411066 15451040 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 3.14 | 16940565 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.57 | 17268249 17109627 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 8.15 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 8.15 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 8.15 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 8.15 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 3.16 | 17112576 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 6.64 | 11903285 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 6.64 | 11701602 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 6.64 | 18803445 18765137 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 3.86 | 14659530 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.28 | 15792986 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 19.36 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 19.36 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 19.36 | 18986760 16757204 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 19.36 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Plant Preparations | 19.36 | 17418620 | |
| MESH:D009062 | Mouth Neoplasms | Sirolimus | 19.36 | 19435901 | |
| MESH:D052016 | Mucositis | Doxorubicin | 8.18 | 17415656 | |
| MESH:D052016 | Mucositis | Methotrexate | 8.18 | 17488658 | |
| MESH:D009101 | Multiple Myeloma | 2,5-dimethylcelecoxib | 54.46 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 54.46 | 11468182 14977855 19417148 15949261 19549372 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 54.46 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | bortezomib | 54.46 | 19372569 19112201 19112817 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 54.46 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 54.46 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | CPS 11 | 54.46 | 15858615 | |
| MESH:D009101 | Multiple Myeloma | CPS 49 | 54.46 | 15858615 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 54.46 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 54.46 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 54.46 | 15867202 15744524 16118317 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 54.46 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 54.46 | 17935668 17049120 14749477 17164350 16267019 16490592 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 54.46 | 19372569 17168659 15741222 19112201 15939924 15867202 15920492 16445831 19112817 15744524 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 54.46 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 54.46 | 19621390 16996129 18089719 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 13.64 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 13.64 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 13.64 | 17962980 | |
| MESH:D009135 | Muscular Diseases | orlistat | 6.50 | 18430571 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 6.50 | 16239165 | |
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 2.81 | 8888407 | |
| MESH:D009145 | Mushroom Poisoning | Silymarin | 5.60 | 17213517 | |
| MESH:D009164 | Mycobacterium Infections | Ciprofloxacin | 7.26 | 10063276 | |
| MESH:D009164 | Mycobacterium Infections | orlistat | 7.26 | 21442799 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.34 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 20.30 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | Ciprofloxacin | 20.30 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 20.30 | 19157545 19010910 16882708 18608210 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 20.30 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 20.30 | 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 20.30 | 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 20.30 | 17596541 | |
| MESH:D009196 | Myeloproliferative Disorders | WP1066 | 5.79 | 18245540 | |
| MESH:D009203 | Myocardial Infarction | alpha-Tocopherol | 14.97 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | Cocaine | 14.97 | 18072171 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 14.97 | 15857846 19429709 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 14.97 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 14.97 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 14.97 | 16525036 16317513 17188708 17015251 17125593 16456233 | |
| MESH:D009203 | Myocardial Infarction | SB 216763 | 14.97 | 16288908 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 5.26 | 17125593 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 5.26 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 4.78 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 4.78 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.45 | 17322642 | |
| MESH:D009325 | Nausea | vorinostat | 4.20 | 20479100 | |
| MESH:D016870 | Neisseriaceae Infections | Ciprofloxacin | 5.03 | 20378725 | |
| MESH:D009361 | Neoplasm Invasiveness | Amiloride | 14.51 | 14644129 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 14.51 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 14.51 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 14.51 | 18047805 | |
| MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 24.87 | 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 24.87 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | bendamustine | 24.87 | 17667603 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 24.87 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Disulfiram | 24.87 | 15367699 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 24.87 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 24.87 | 11239499 16537180 11053908 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 24.87 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 24.87 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 24.87 | 15867366 17312309 19139120 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.90 | 19410462 | |
| MESH:D009369 | Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 56.47 | 8820588 | |
| MESH:D009369 | Neoplasms | 2'-benzoyloxycinnamaldehyde | 56.47 | 17855188 | |
| MESH:D009369 | Neoplasms | Acrolein | 56.47 | 17329238 | |
| MESH:D009369 | Neoplasms | alitretinoin | 56.47 | 16946489 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 56.47 | 11141357 | |
| MESH:D009369 | Neoplasms | Berberine | 56.47 | 12415430 | |
| MESH:D009369 | Neoplasms | Carboplatin | 56.47 | 17925555 18854779 | |
| MESH:D009369 | Neoplasms | Cisplatin | 56.47 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 56.47 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 56.47 | 17925555 19470736 19116145 | |
| MESH:D009369 | Neoplasms | deguelin | 56.47 | 17764071 | |
| MESH:D009369 | Neoplasms | Dieldrin | 56.47 | 8820588 | |
| MESH:D009369 | Neoplasms | Disulfiram | 56.47 | 17079463 | |
| MESH:D009369 | Neoplasms | Fenretinide | 56.47 | 15958647 17353921 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 56.47 | 18239605 18600527 16928823 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 56.47 | 15533788 | |
| MESH:D009369 | Neoplasms | orlistat | 56.47 | 18710210 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 56.47 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 56.47 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 56.47 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 56.47 | 16594593 16946489 | |
| MESH:D009369 | Neoplasms | ursolic acid | 56.47 | 8847885 | |
| MESH:D009374 | Neoplasms, Experimental | erythritol anhydride | 19.25 | 10925838 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 19.25 | 10663608 15625704 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 19.25 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | orlistat | 19.25 | 19381703 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 19.25 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 19.25 | 20056578 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 10.82 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 10.82 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 10.82 | 19189210 19200415 19196722 | |
| MESH:D009389 | Neovascularization, Pathologic | 2-methoxyestradiol-3,17-bis-O,O-sulfamate | 18.26 | 17426705 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 18.26 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 18.26 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 18.26 | 15367699 | |
| MESH:D009389 | Neovascularization, Pathologic | orlistat | 18.26 | 17012255 | |
| MESH:D009393 | Nephritis | Acrolein | 4.95 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 3.19 | 15464296 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.48 | 16899518 16636307 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 2.84 | 16889571 15640375 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 4.99 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 4.99 | 17356569 18619942 15790535 | |
| MESH:D009421 | Nervous System Malformations | Benomyl | 13.39 | 14502586 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 13.39 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 13.39 | 16859833 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 13.39 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.29 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 22.57 | 6679447 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 22.57 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 22.57 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 22.57 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | Folic Acid | 22.57 | 17438019 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 22.57 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 22.57 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 22.57 | 16359493 8888407 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 4.17 | 11555667 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.90 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 9.02 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 9.02 | 8761367 15176712 16115947 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 9.02 | 15555623 | |
| MESH:D009447 | Neuroblastoma | WP 744 | 9.02 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 18.24 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 18.24 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 18.24 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 18.24 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 18.24 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 18.24 | 16850258 17266991 | |
| MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 11.74 | 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 11.74 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 11.74 | 8761367 12837982 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 10.80 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 10.80 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 10.80 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.78 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.36 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 5.06 | 11005259 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 5.06 | 16436463 | |
| MESH:D009503 | Neutropenia | Ciprofloxacin | 12.15 | 17846019 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 12.15 | 8291058 | |
| MESH:D009503 | Neutropenia | Folic Acid | 12.15 | 16322990 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 12.15 | 16761898 7688884 | |
| MESH:C541083 | Non-alcoholic Fatty Liver Disease | orlistat | 4.34 | 17404856 | |
| MESH:D009765 | Obesity | 2-chloroethyl ethyl sulfide | 12.43 | 16289378 | |
| MESH:D009765 | Obesity | Ascorbic Acid | 12.43 | 17217161 | |
| MESH:D009765 | Obesity | Capsaicin | 12.43 | 19056576 | |
| MESH:D009765 | Obesity | Curcumin | 12.43 | 19297423 | |
| MESH:D009765 | Obesity | orlistat | 12.43 | 20065556 20518802 18773755 19461584 16938137 21442799 21438711 20540997 19207292 20002075 19046740 20599501 | |
| MESH:D009765 | Obesity | pirinixic acid | 12.43 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 12.43 | 19056576 20132043 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.84 | 6374098 | |
| MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 8.43 | 6482804 4026338 | |
| MESH:D009784 | Occupational Diseases | 4-amino-2,6-dinitrotoluene | 8.43 | 14694615 | |
| MESH:D009784 | Occupational Diseases | Benzene | 8.43 | 15576619 15935809 17479406 15612468 15913788 15727169 16737584 17119257 17178637 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.42 | 16517039 | |
| MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 3.68 | 3988306 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 2.73 | 7009135 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 7.95 | 15867366 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 7.95 | 15867366 | |
| MESH:D010024 | Osteoporosis | Curcumin | 4.43 | 18719352 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 4.43 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 9.92 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 9.92 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 9.92 | 17513867 | |
| MESH:C536063 | Osteoporosis-pseudoglioma syndrome | pamidronate | 5.71 | 18825883 | |
| MESH:D012516 | Osteosarcoma | Disulfiram | 6.57 | 18047805 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 6.57 | 15930896 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 39.90 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 39.90 | 12452020 19769630 16624393 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 39.90 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 39.90 | 6897625 15464296 17225452 19769630 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 39.90 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 39.90 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Disulfiram | 39.90 | 17026967 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 39.90 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 39.90 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 39.90 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 39.90 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 39.90 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 39.90 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 39.90 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 39.90 | 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 39.90 | 16211241 | |
| MESH:D010146 | Pain | Acetaminophen | 15.06 | 16870215 | |
| MESH:D010146 | Pain | Capsaicin | 15.06 | 17043245 17434803 17084039 16996476 19081190 18987195 | |
| MESH:D010146 | Pain | Cyclophosphamide | 15.06 | 12161096 18093676 | |
| MESH:D010146 | Pain | Indomethacin | 15.06 | 17627676 3291741 13679232 17440234 | |
| MESH:D010146 | Pain | Sulindac | 15.06 | 3291741 | |
| MESH:D010146 | Pain | Tretinoin | 15.06 | 16870215 | |
| MESH:D010146 | Pain | zoledronic acid | 15.06 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 3.36 | 18702446 12538197 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 50.39 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 50.39 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 50.39 | 19196508 17440100 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 50.39 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 50.39 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | dehydroxymethylepoxyquinomicin | 50.39 | 16211219 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 50.39 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 50.39 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 50.39 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 50.39 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 50.39 | 16500647 16929163 15113037 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | gemcitabine | 50.39 | 11504793 18383843 17440100 18992248 16929163 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 50.39 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 50.39 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 50.39 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 50.39 | 16820089 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 50.39 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 50.39 | 19294695 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 5.07 | 15028970 17883296 | |
| MESH:D010195 | Pancreatitis | orlistat | 5.07 | 20065556 16938137 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.45 | 11578682 | |
| MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 8.35 | 7296757 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 8.35 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 8.35 | 16517061 15173996 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.92 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.38 | 16537180 | |
| MESH:D010291 | Paresis | Thalidomide | 4.97 | 9200351 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 10.81 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Dieldrin | 10.81 | 16809432 11181820 11445065 16112328 17291500 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 10.81 | 16510128 15451049 11181820 16140633 11124998 12911755 15824117 11445065 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 10.81 | 19232380 15451049 18191903 19114014 18619942 11445065 16412576 11535288 16140633 | |
| MESH:D010300 | Parkinson Disease | Selegiline | 10.81 | 18328768 | |
| MESH:D010300 | Parkinson Disease | Sirolimus | 10.81 | 19682553 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 3.15 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 5.46 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 5.46 | 18197244 15927086 15574749 15795934 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.38 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.91 | 12520081 | |
| MESH:D010391 | Pemphigoid, Bullous | Niacinamide | 5.12 | 11026799 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.84 | 11148446 | |
| MESH:D010518 | Periodontitis | Indomethacin | 3.59 | 17225004 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 3.07 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 4.07 | 15687053 | |
| MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 14.93 | 6228378 | |
| MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 14.93 | 11550810 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 14.93 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.82 | 17983394 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.56 | 15087411 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.53 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.53 | 17638057 | |
| MESH:D011014 | Pneumonia | Bleomycin | 7.12 | 16317386 17071938 18024389 | |
| MESH:D011014 | Pneumonia | Paraquat | 7.12 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 4.03 | 18573544 | |
| MESH:D011041 | Poisoning | Mustard Gas | 2.62 | 15727166 | |
| MESH:D011085 | Polycystic Ovary Syndrome | orlistat | 4.09 | 17201808 | |
| MESH:D011087 | Polycythemia Vera | WP1066 | 5.45 | 18245540 | |
| MESH:D017499 | Porokeratosis | alitretinoin | 4.67 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.30 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 5.36 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 5.36 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 7.19 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 7.19 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 7.19 | 17031469 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 3.08 | 17114810 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.83 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 8.83 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 8.83 | 11222880 11118676 11896295 11399792 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 8.83 | 20603192 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 8.16 | 17616702 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 8.16 | 17616702 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 15342424 | ||
| MESH:D011471 | Prostatic Neoplasms | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester | 23.77 | 16039525 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 23.77 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 23.77 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Berberine | 23.77 | 16505103 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 23.77 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 23.77 | 17908994 15570007 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 23.77 | 17308104 17079463 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 23.77 | 10851300 18156803 15129424 11398177 18769126 12497104 18226269 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 23.77 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Disulfiram | 23.77 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | docetaxel | 23.77 | 18824434 16644109 16520278 19103299 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 23.77 | 16729912 15897917 16888761 18437689 15749863 16868541 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 23.77 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 23.77 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | fisetin | 23.77 | 18922931 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 23.77 | 19082440 18626508 | |
| MESH:D011471 | Prostatic Neoplasms | gefitinib | 23.77 | 15651060 16685379 17914592 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 23.77 | 15682402 12376480 | |
| MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 23.77 | 16205645 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 23.77 | 16729912 17172428 17136230 16356831 | |
| MESH:D011471 | Prostatic Neoplasms | panduratin A | 23.77 | 16497706 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 23.77 | 14666653 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 23.77 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 23.77 | 17675339 17718901 17636462 15767336 17804756 16731767 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 23.77 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 23.77 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 23.77 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 23.77 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 23.77 | 19789329 18798265 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 23.77 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | vorinostat | 23.77 | 17218635 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 23.77 | 16700911 16517595 16606632 12429649 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 23.77 | 12438248 19103299 | |
| MESH:D011507 | Proteinuria | Indomethacin | 5.28 | 11849393 | |
| MESH:D011507 | Proteinuria | Tretinoin | 5.28 | 16636307 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.97 | 12755975 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 5.25 | 15861022 16919318 | |
| MESH:D011537 | Pruritus | Mustard Gas | 5.25 | 18058305 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 3.21 | 12752131 11422049 | |
| MESH:D011565 | Psoriasis | Methotrexate | 2.79 | 17410198 | |
| MESH:D011618 | Psychotic Disorders | Cocaine | 3.77 | 16134406 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.48 | 16723453 | |
| MESH:D011654 | Pulmonary Edema | Bleomycin | 7.28 | 15808516 | |
| MESH:D011654 | Pulmonary Edema | Oleic Acid | 7.28 | 15090967 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.33 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | alpha-Tocopherol | 8.63 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 8.63 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Bleomycin | 11.97 | 16115399 21435439 16314464 12624602 15541506 17434272 14609568 17177178 17241526 15322207 18008008 18162602 12574379 11554783 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 11.97 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 11.97 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | gefitinib | 11.97 | 18424623 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 11.97 | 17620002 17266442 17720292 17894541 10334151 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 11.97 | 17997886 16324872 | |
| MESH:D012003 | Rectal Fistula | Ciprofloxacin | 10.20 | 18371140 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 10.20 | 15043669 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.84 | 18286688 16160472 18722050 15538739 | |
| MESH:D012035 | Refsum Disease | orlistat | 4.76 | 20871815 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 18.66 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 18.66 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 18.66 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Folic Acid | 18.66 | 15728788 | |
| MESH:D051437 | Renal Insufficiency | Methotrexate | 18.66 | 17352296 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.25 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 6.02 | 18460982 19211983 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 6.02 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 6.02 | 17520802 16314181 15827377 17058453 16317513 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | 2-chloroethyl ethyl sulfide | 23.79 | 16292752 12210543 18257742 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 23.79 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 23.79 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 23.79 | 18379247 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oleic Acid | 23.79 | 18549715 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 23.79 | 18339021 17627322 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 23.79 | 11700416 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 2.80 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.57 | 18990726 | |
| MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 16.46 | 3692021 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 16.46 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 16.46 | 18155124 18172121 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 16.46 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 16.46 | 16584753 | |
| MESH:D012174 | Retinitis Pigmentosa | alpha-Tocopherol | 4.02 | 16849425 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 4.02 | 16849425 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 4.17 | 11555667 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 11.39 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 11.39 | 16283617 16116481 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 11.39 | 19155313 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 3.96 | 15015336 | |
| MESH:D012509 | Sarcoma | Curcumin | 5.63 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 5.63 | 17710206 15675481 15625365 18313854 16767912 17203757 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 24.21 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 24.21 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 24.21 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 24.21 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 24.21 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 24.21 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.48 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.21 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 4.19 | 9673227 | |
| MESH:D012559 | Schizophrenia | Copper | 3.35 | 16842975 | |
| MESH:D012559 | Schizophrenia | Folic Acid | 3.35 | 16641680 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 3.35 | 19110320 15737665 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.62 | 16096327 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.58 | 16636934 | |
| MESH:D012640 | Seizures | Cocaine | 6.10 | 10454489 | |
| MESH:D012640 | Seizures | Ethanol | 6.10 | 9754883 | |
| MESH:D012640 | Seizures | Sulfonamides | 6.10 | 20420384 | |
| MESH:D012640 | Seizures | Valproic Acid | 6.10 | 14763951 16876388 15475178 11738929 11044598 1511512 3137016 17978042 | |
| MESH:D018805 | Sepsis | Curcumin | 2.94 | 18389075 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 3.40 | 7327846 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 8.45 | 18709164 | |
| MESH:D012871 | Skin Diseases | Folic Acid | 8.45 | 18709164 | |
| MESH:D012871 | Skin Diseases | monomethylarsonous acid | 8.45 | 17431481 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 8.45 | 12880345 16961503 15451306 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 8.45 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 30.06 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | deguelin | 30.06 | 16041863 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 30.06 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 30.06 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 30.06 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Okadaic Acid | 30.06 | 12628509 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 30.06 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 30.06 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 30.06 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 30.06 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 30.06 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 30.06 | 16467112 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 4.01 | 15464296 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.28 | 17203757 15625365 16767912 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 7.17 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 7.17 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.20 | 16517039 | |
| MESH:D013118 | Spinal Cord Diseases | Folic Acid | 4.18 | 16361298 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 2.74 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 5.84 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 5.84 | 19490988 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 3.21 | 12833885 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 6.08 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 6.08 | 10192188 10486359 16280098 15038085 18545984 10215738 16113693 17207306 18209964 15472012 17160473 17638125 16184426 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 32.82 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 32.82 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 32.82 | 2093021 20155912 | |
| MESH:D013274 | Stomach Neoplasms | Butylated Hydroxyanisole | 32.82 | 1399818 3581430 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 32.82 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 32.82 | 17522103 15958060 18396642 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 32.82 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 32.82 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | docetaxel | 32.82 | 16557585 | |
| MESH:D013274 | Stomach Neoplasms | Docosahexaenoic Acids | 32.82 | 19015929 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 32.82 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 32.82 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 32.82 | 18396642 16951190 18567086 15786421 16424979 19084572 17522103 19015929 17498489 17172411 | |
| MESH:D013274 | Stomach Neoplasms | Folic Acid | 32.82 | 17171786 | |
| MESH:D013274 | Stomach Neoplasms | gambogic acid | 32.82 | 19084572 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 32.82 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 32.82 | 16257854 15930296 18593901 | |
| MESH:D013274 | Stomach Neoplasms | orlistat | 32.82 | 19381703 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 32.82 | 18396642 18506536 | |
| MESH:D013274 | Stomach Neoplasms | styrene oxide | 32.82 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 32.82 | 17261132 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 22.52 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 22.52 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 22.52 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 22.52 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 22.52 | 17189318 11906479 9211565 16755016 9562338 17918041 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 22.52 | 15138204 18237397 18181030 11729361 17918041 10750652 11906479 12787963 17895592 17654042 17135157 11595431 1323529 18726076 10878458 16252198 16631530 18299717 18209962 12498302 12077510 18193104 16397915 16934674 10423059 16150113 17627676 11145282 18543354 14567935 18431645 16169175 17977527 11595415 16755016 12467913 15104355 12500499 18087811 17657623 15255614 11523592 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 22.52 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 22.52 | 18237397 12787963 17135157 18193104 15255614 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 22.52 | 15138204 | |
| MESH:D020521 | Stroke | Acrolein | 11.45 | 16269634 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 11.45 | 16517955 16403987 | |
| MESH:D020521 | Stroke | Folic Acid | 11.45 | 16517955 | |
| MESH:D020521 | Stroke | Vitamin E | 11.45 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.28 | 16321402 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 9.27 | 17634840 | |
| MESH:D013345 | Subarachnoid Hemorrhage | pifithrin | 9.27 | 18364113 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 3.07 | 9754883 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 4.23 | 12563064 | |
| MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 8.14 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 8.14 | 12837982 | |
| MESH:D013576 | Syndactyly | Methotrexate | 3.77 | 9562676 | |
| MESH:D024801 | Tauopathies | Camptothecin | 7.51 | 16930453 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 7.51 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 15.03 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 15.03 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | polyphenols | 15.03 | 17997062 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.39 | 15464296 17225452 | |
| MESH:D013921 | Thrombocytopenia | vorinostat | 3.79 | 20479100 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.38 | 11994571 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.01 | 15669648 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 7.89 | 10850423 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 7.89 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.57 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 27.97 | 6587162 1399818 6582329 7505956 3712494 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 27.97 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 27.97 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 27.97 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 27.97 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 27.97 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | gefitinib | 27.97 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 27.97 | 14736730 18791128 11352223 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 27.97 | 7505956 3078959 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 27.97 | 16026305 17045167 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 13.97 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 13.97 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 13.97 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 13.97 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.68 | 15213294 | |
| MESH:D014123 | Toxoplasmosis | Ciprofloxacin | 4.69 | 20186551 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 3.90 | 17262798 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 2.26 | 16040207 | |
| MESH:D014402 | Tuberous Sclerosis | Sirolimus | 4.30 | 18495876 21115397 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.59 | 10574470 17380554 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.21 | 3119515 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 39.79 | 8074119 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 39.79 | 12845720 11780464 20435036 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 39.79 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Butylated Hydroxyanisole | 39.79 | 1399818 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Ciprofloxacin | 39.79 | 15028437 10741713 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 39.79 | 15464296 12973940 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 39.79 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 39.79 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 39.79 | 19087683 17616700 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 39.79 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 39.79 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 39.79 | 20375083 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Plant Preparations | 39.79 | 11251952 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 39.79 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 39.79 | 16452187 17306315 11723127 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 39.79 | 17572228 16712894 8653321 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.35 | 8888407 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.95 | 18462866 | |
| MESH:D014570 | Urologic Diseases | cypermethrin | 4.54 | 16487989 | |
| MESH:D014581 | Urticaria | Acetaminophen | 1.79 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 26.58 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 26.58 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 26.58 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 26.58 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 26.58 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 26.58 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 26.58 | 16129372 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 21.40 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 21.40 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 21.40 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 21.40 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 21.40 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 21.40 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 8.43 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 8.43 | 16752155 | |
| MESH:D014605 | Uveitis | Dexamethasone | 7.98 | 1336536 | |
| MESH:D014605 | Uveitis | Sirolimus | 7.98 | 1336536 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 3.33 | 15577323 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.79 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 7.79 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.26 | 12125929 | |
| MESH:D020301 | Vasospasm, Intracranial | pifithrin | 4.32 | 18364113 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.33 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 9.90 | 17678736 17334414 17638931 16364871 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 9.90 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 9.90 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 4.01 | 18097624 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.80 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 7.15 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 7.15 | 11897121 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.91 | 15886252 | |
| MESH:D015431 | Weight Loss | Bleomycin | 4.34 | 12624602 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.79 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 5.37 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 5.37 | 19894650 20213670 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:03410 | Base excision repair |
| No data |
| Releated disease ID | Related disease Name |
|---|---|
| PA446969 | Venous Thrombosis |
| PA445113 | Neutropenia |
| PA445062 | Neoplasms |
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| PA443560 | Breast Neoplasms |
| PA152132901 | Hereditary Breast/Ovarian Cancer Syndrome |
| PA445204 | Ovarian Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA164920420 | Olaparib |
| PA451644 | thalidomide |
| PA450085 | irinotecan |
| PA449748 | gemcitabine |
| PA452621 | antineoplastic agents |
| PA165291474 | BSI-201 |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB02498 | - | Carba-Nicotinamide-Adenine-Dinucleotide | |
| DB02690 | - | NU1025 | |
| DB02701 | binder | Nicotinamide | Vitamin B Complex |
| DB03072 | - | 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone | |
| DB03073 | - | 3-Methoxybenzamide | Enzyme Inhibitors |
| DB03509 | - | 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide | |
| DB03722 | - | 3,4-Dihydro-5-Methyl-Isoquinolinone | |
| DB04010 | - | 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide | |
| DB07096 | - | 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE | |
| DB07232 | - | (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium | |
| DB07330 | - | trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium | |
| DB07787 | - | 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE |
| No data |
| No data |
| No data |